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Abstract 
Anabolic-androgenic steroid (AAS) use is a global public health concern. However, the 
relationship between AAS use and its psychological side effects, specifically aggression 
needs further elucidation. Results from experimental studies on this topic are inconsistent. 
Moreover, no previous study has examined patterns of aggression and psychological distress 
among male and female AAS users. Finally, although some studies have examined risk 
factors of AAS use in cross-sectional samples, there is a dearth of longitudinal studies on 
prevalence and risk factors for AAS use, particularly aggression, from late adolescence to 
early adulthood. Three studies were conducted to shed light on the aforementioned gaps in 
the literature. The aim of the first study was to systematically review and meta-analyse 
results from human randomized controlled trials (RCTs) on the effect of AAS administration 
on aggression. The second study aimed to investigate the patterns of aggression and 
psychological distress among AAS users among male and female AAS users. The third 
study aimed to examine the prevalence of AAS use, and longitudinal risk factors for AAS 
use intent, especially physical and verbal aggression, from late adolescence to early 
adulthood.  
A systematic review and meta-analysis was conducted to accomplish the first study’s aim. 
Twelve RCTs comprising a total of 562 healthy males were identified and included in the 
meta-analysis after systematic searches of MEDLINE, PsycINFO, ISI Web of Science, 
ProQuest, Google Scholar, and the Cochrane Library. The Q-statistic and I2 index were 
utilized to assess heterogeneity. Additionally, to achieve the aim of the second study, a 
cross-sectional survey was conducted on 206 AAS users (females = 58.30%) in Iran. 
Participants’ ages ranged from 14 to 56 (M = 26.86, SD = 7.12). Data was collected from 
Tehran, Iran. The questionnaire comprised questions on demographics, AAS use, aggression 
and psychological distress. A multigroup latent class analysis (MLCA) was conducted to 
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elucidate patterns of aggression and psychological distress among this sample. Measurement 
invariance examined sex-specificity of identified patterns of aggression and psychological 
distress. Moreover, to accomplish the aim of the third study, a longitudinal study of the 
prevalence of AAS use, and risk factors of AAS use intent, particularly the role of physical 
and verbal aggression from age 18 to 19 was conducted in Norway. At the first wave, 1,333 
18-year-olds (females = 58.9%) completed a questionnaire containing demographic, AAS 
use and intent, other substance (alcohol, cigarette, and snus) use, aggression, anxiety, and 
depression. At age 19 (N = 1277, females = 61.7%), they completed the same set of 
questionnaires. To analyse the data descriptive statistics, correlations, and hierarchical 
multiple regression were utilized 
Results of the first study, after excluding an outlier, indicated that AAS administration is 
associated with a small increase in self-reported aggression using a random-effects model. 
This result was replicated when restricting the analysis to the effect of acute AAS 
administration on self-reported aggression under a fixed-effect model. For the second study, 
the MLCA identified five subgroups of AAS users. The first and smallest subgroup (7.63%) 
comprised highly aggressive and moderately distressed users. The second subgroup 
(18.64%) consisted of moderately aggressive and distressed users. The third subgroup 
(22.95%) was composed of users with moderate levels of direct aggression (physical and 
verbal aggression) as well as distress, and mild levels of indirect aggression (anger and 
hostility). The fourth subgroup (11.71%) was made up of users with mild levels of direct 
aggression and moderate levels of indirect aggression and psychological distress. Finally, the 
fifth and largest subgroup (39.06%) encompassed users with low levels of aggression and 
mild levels of psychological distress. Results from measurement invariance analysis 
indicated that a homogenous five-class solution is the best model for both sexes. However, 
sex was significantly associated with the probability of belongingness to subgroups with 
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members of the highly aggressive and moderately distressed subgroup more likely to be 
male users whereas members of the fifth subgroup were more likely to be female. Results of 
the third study indicated an AAS use prevalence of 1 person at age 18 to 4 persons at age 19. 
AAS use intent, being male, living alone, and actual AAS use at age 18 were predictive risk 
factors of AAS use intent at age 19. From age 18 to 19, physical aggression and verbal 
aggression decreased significantly in both sexes and, did not predict AAS use intent at age 
19. 
Altogether, it can be inferred from the above results that AAS administration increases 
aggression in RCTs. Additionally, the above results provide evidence of the idiosyncratic 
patterns of aggression and psychological distress among male and female AAS users, and 
denote the lack of prospective associations between physical or verbal aggression and AAS 
use intent from ages 18 to 19. Findings from these studies contribute to the evidence base on 
AAS use and aggression. Potential applications of these findings in future research, 
policymaking and public health interventions is also discussed. 
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1.1 Anabolic-androgenic steroids 
Anabolic-androgenic steroids (AAS) are a family of drugs comprising the male 
hormone testosterone and its synthetic derivatives (Kanayama & Pope, 2018). These drugs 
have been developed over the last 75 years. AAS possesses both anabolic (i.e., facilitating 
muscle building and fat loss) and androgenic (i.e., masculinization properties such as 
deepening of the voice, sperm production, and growth of pubic hair) effects. Even though the 
pharmaceutical industry has produced substances in which the androgenic effects have been 
minimized and the main effects are anabolic, yet both effects of AAS are inseparable (Pope 
et al., 2013). Thus, in this thesis, AAS refers to testosterone and its synthetic derivatives 
which have inseparable anabolic and androgenic effects. 
During the early years of the twentieth century, testicular dysfunction was treated 
with transplanting animal and human testicular material into patients (Hoberman & Yesalis, 
1995). In the 1930s scientists isolated and synthesized the hormone testosterone and showed 
its anabolic effects, abolishing the aforementioned practice (Butenandt & Hanisch, 1935). 
Shortly thereafter, testosterone and its synthetic derivatives were available for both oral and 
injectable administration to the medical community. In the 1940s, AAS was used in the 
medical community to treat hypogonadism, anemia (Behre & Nieschlag, 2012) and 
depression in men (Altschule & Tillotson, 1948). AAS was shown to be effective with 
several patients reporting euphoria and increased libido after use (Altschule & Tilloston, 
1948). In recent years, AAS have been clinically administered for revitalizing aging in men, 
and for the treatment of male hypogonadism (Behre & Nieschlag, 2012). AAS have also 
been prescribed for patients with muscle contusion injury, breast cancer, and for the 
prevention of muscle wasting in patients suffering from diseases such as AIDS, osteoporosis, 
and chronic obstructive pulmonary disease (Beiner et al., 1999; Bhasin et al., 2010; Ferreira 
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et al., 1998; Johns et al., 2005; Rabkin et al., 1995; Tenover, 1994). Additionally, it has been 
suggested that AAS can be used by males with type 2 diabetes or hypogonadism to increase 
their libido, energy level, and bone density and decrease their anemia and fat storage thereby 
improving their overall quality of life (Caliber & Hackett, 2019). AAS are also administered 
to postmenopausal women to increase their libido (Islam et al., 2019). 
Boje (1939) first suggested that sex hormones improve physical performance. 
Simultaneously, the anabolic effects of testosterone were being assessed in normal men and 
women (Kenyon et al., 1940; Simonson et al., 1944). From the 1960s however, non-medical 
use of AAS has been associated with ‘doping’. In this period, AAS was mainly used by elite 
athletes and bodybuilders in order to increase their muscle mass and their performance. 
Additionally, during this era, the German Democratic Republic (GDR) arranged a program 
about AAS doping for their Olympic athletes. After the collapse of GDR in 1990s, classified 
documents indicated that from 1966 onward, the program consisted of physicians and 
scientists who worked on development and administration of AAS on thousands of athletes 
(Hoberman, 1992).  
From the 1970s, AAS use shifted from elite athletes and bodybuilders into the non-
athletic population (Kanayama & Pope, 2018; Maravelias et al., 2005). Today, they are 
predominantly used as illicit self-administration drugs, where supratherapeutic doses are 
typically used to enhance performance and physical appearance among the general 
population (Bahrke & Yesalis, 2004). Thus, being a professional athlete and sports 
participation are no longer the primary risk factor for AAS use (Harmer, 2010). A meta-
analysis on the global prevalence of AAS use estimated that 3.3% of the world’s population 
has used AAS at least once with use being, expectedly, more popular among men (6.4%) 
compared to women (1.6%) (Sagoe et al., 2014a). Indeed, in this meta-analysis AAS was 
most prevalent among recreational sportspersons (18.4%) followed by athletes (13.4%). 
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AAS can be self-administered orally in the form of pills, parenterally by 
intramuscular injection, or transdermally in the form of patches or topical gel (van de Ven et 
al., 2020). It has been indicated that since data on AAS are increasingly being collected 
within Needle and Syringe Programs (NSPs), non-injectors have become an overlooked 
group of AAS users and require attention (van de Ven et al., 2020). Users typically 
administer AAS in phases known as “cycles”. The two main cycles are “on cycle” which is 
the phase in which AAS is used and typically lasts from 6 to 18 weeks (Copeland et al., 
2000) and the “off cycle” which is a phase where no AAS is used. The purpose of the “off 
cycle” is to prevent tolerance and the experience of side-effects as well as getting the natural 
production of androgens back to their normal activity and level. In this off period some 
facilitates this by drugs, such as clomiphene, which blocks the estrogen receptors in the 
hypothalamus, with increased release of luteinizing hormone (LH) and follicle-stimulating 
hormone (FSH) as result. Also, other drugs may be used to reduce catabolic effects of 
cortisol.  
Collectively, the measures taken to lessen the side-effects of AAS and to re-initiate 
the natural production of androgens are referred to as post cycle therapy (Griffiths et al., 
2017). Another mode of AAS use is called “blitz-cycling” which is when users constantly 
change the type of AAS they administer in order to avert tolerance and androgen receptor 
down-regulation. Also, the “blast and cruise” mode of use is when users do not have an “off 
cycle” phase but instead switch between administrating high (blast) and low (cruise) dosages 
(Sagoe et al., 2015a). “Stacking” is another mode of administration AAS referring to the use 
of different types of AAS concurrently in order to ensure saturation of all androgen 
receptors, increase metabolism, enhance performance, build muscle, or counter unwanted 
effects of other AAS (Backhouse, 2012; Hoffman & Ratamess, 2006). Additionally, AAS is 
often used concurrently with other licit or illicit drugs in order to increase the effectivity of 
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AAS or for other purposes (Dodge & Hoagland, 2011). AAS users typically self-administer 
supraphysiologic doses over relatively long periods (Pope & Kanayama, 2012).  
1.2 Typologies of AAS users 
AAS users are a heterogeneous population amongst which there is variation in terms 
of motives for use, predispositions, and risk factors for use. Some studies have sought to 
identify subgroups of AAS users based on motives for use and approaches toward AAS. 
After systematically synthesizing studies regarding the experiences of AAS users, a review 
identified four main subgroups of AAS users: aesthetic users, occupational (non-sporting) 
users, psychological users, and sports users (Sagoe, 2014). Aesthetic users are mostly 
concerned with their body image and their main purpose of AAS use is to enhance their 
appearance and sexual attractivity. Occupational users engage in AAS use to enhance their 
aggression and body strength, personal security, and sexual attraction. This group typically 
include criminals, security workers, and male models. Psychological users such as persons 
with psychological problems, like low self-esteem or depression utilize AAS in order to 
enhance their confidence, and psychological well-being. Finally, sports users include 
competitive and recreational sportspeople (e.g., bodybuilders, athletes, and weightlifters) 
with enhanced aggression and muscle mass, physiological recovery, athletic performance 
and injury prevention as their main purposes for AAS use. It should be noted that some 
individuals may belong to one or more subgroups. 
A qualitative study (Christiansen et al., 2017) presented a typology based on men’s 
approach to AAS use in which four user types are proposed. These typologies have received 
empirical support from a study of 611 AAS users from England, Scotland and Wales 
(Zahnow et al., 2018). First is the expert type (24.9%) in which the user chooses the safest 
and most effective way of AAS utilization by achieving knowledge regarding dosage, 
concurrent use with other drugs, and possible cycles on websites and blogs. Second is the 
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well-being type (38.6%) comprising users whose priority is to experience physical, mental, 
and social well-being. Such users try to keep the risks of AAS use as low as possible. The 
“You Only Live Once” (YOLO) type (11.1%) represents users who are more likely into junk 
food, alcohol consumptions, and other recreational drugs. These AAS users’ main aim is 
looking muscular in order to achieve high social status and are not concerned with AAS 
side-effects. The YOLO type is more likely to be aggressive and end up in fights and they 
are more likely to use stimulants concurrently (Zahnow et al., 2018). The athlete type 
(25.4%) represents a user committed to competitive sports and his/her main focus is to 
achieve his goal. He/she trains hard and avoids junk food and alcohol. If he notices that 
fellow competitors are using higher dosages of AAS, he will typically utilize higher dosages 
as well (Christiansen et al., 2017; Zahnow et al., 2018). 
Subgroups of appearance- and performance-enhancing drug (APED) users have also 
been examined by Hildebrandt et al. (2007). Results of that study indicated that patterns of 
APED use depend on different training goals and identities. The first subgroup of APED 
users was heavy polypharmacy users including body builders who used high dosages for 
long periods. The second subgroup comprised the fat-burning group who identified 
themselves as power lifters and used APED in order to add muscle mass. The third subgroup 
primarily included the mass-making group consisting of users who preferred lean muscles 
and were more likely to be fitness or endurance athletes. Finally, the fourth subgroup 
consisted of the normal APED group including the majority of participants and they used 
low to moderate dosages of AAS for shorter periods of time. Those in this group identified 
themselves as recreational weightlifters (Hildebrandt et al., 2007). Identifying the motives 
and risk factors for AAS use and subgroups of AAS users can help design prevention 
policies and identify at risk subgroups of users (Harvey, 2020). 
1.3 Adverse effects of AAS use  
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The benefits of AAS mentioned by users include gained muscle mass, improved 
performance and enhanced appearance, boosted confidence, elevated mood, and increased 
libido (Davis & Arnocky, 2020; Mey et al., 2018; Smit et al., 2020). However, it has been 
shown that when administered illicitly, users experience various side effects or harms 
particularly after a long-term use of supraphysiologic doses or when concurrently used with 
other substances (Mey et al., 2018). Some of these harms to health can be permanent (Torrisi 
et al., 2020). 
1.3.1 Harms to the physiological system 
One of the major concerns regarding AAS use is cardiovascular disorders induced by 
AAS use such as cardiomyopathy, high blood pressure, fibrosis, and myocardial infarction 
(Angell et al., 2012; Neto et al., 2018; Baggish et al., 2017; Pirompol et al., 2016). Other 
general effects of AAS encompass sleep abnormalities, hematologic effects, hepatic, 
neuromuscular and skeletal, dermatologic, immunological, and renal impairment (Ganesan et 
al., 2020; Pope et al., 2014a). In males, AAS use has been associated with decreased libido, 
increase in prostate-specific antigen, testicular atrophy, benign prostatic hypertrophy, low 
testosterone level, erectile dysfunction, and oligospermia (Armstrong et al., 2018; Christou 
et al., 2017; Ganesan et al., 2020). In females, AAS use has been linked to lower-pitched 
voice, hirsutism, breast atrophy, male-pattern baldness, clitoromegaly, and irregular menses 
(Bensoussan & Anderson, 2019; Christou et al., 2017). 
1.3.2 Harms to the brain and cognition 
AAS permeate the blood-brain barrier and act on the central nervous system 
(Bertozzi et al., 2018). Recent laboratory and neuroimaging studies have reported deviant 
brain aging (Bjørnebekk et al., 2020), brain abnormalities (Bjørnebekk et al., 2017; Hauger 
et al., 2019) and cognitive impairments such as deficits in retrospective and prospective 
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memory (Heffernan et al., 2015) in long-term AAS users. Additionally, long-term AAS use 
has also been linked to higher risk of dementia (Kaufman et al., 2019). Deficiencies in 
connectivity between brain structures important for normal cognitive and emotional 
functioning such as the amygdala and the default-mode network, the dorsal attention 
network and the superior and inferior frontal gyri, as well as the anterior cingulate cortex are 
also associated with AAS use (Seitz et al., 2017; Westlye et al., 2017). 
1.3.3 Harms to adolescents’ health 
Many studies have raised concerns about the prevalence of AAS use among 
adolescents (Cohen et al., 2007; Dunn & White, 2011; Sagoe et al., 2015c). Evidence from 
systematic reviews suggest that about 13% of AAS users initiate use in adolescence and 
about 20% of adolescents have at least one AAS-using acquaintance (Pope et al., 2014b; 
Sagoe et al., 2014a; Sagoe et al., 2015c). Results from the Youth Risk Behavior Surveillance 
System survey in the United States suggested that 3.2% of all students in grades 9 through 
12 have taken AAS illicitly at some point in their life (Kann et al., 2013). Many adolescents 
believe that they are invulnerable to the physical and psychological harms of AAS use 
(Blahshill, 2014).  
In addition to the harmful effects of AAS mentioned earlier, adolescent AAS use is 
also linked to stunted growth, brain and neurological disorders, and alteration of cognition as 
well as emotional reactivity to social encounters (Cunningham et al., 2013). During 
adolescence some brain organizations which are related to gonadal steroids such as 
testosterone, start to remodel (McCarthy, 2008; Schulz et al., 2009). For example, it has been 
suggested that testosterone levels are positively linked to increase in gray matter in 
adolescent boys (Peper et al., 2009). Moreover, several studies suggest that AAS exposure 
during adolescence can affect amygdala function in anxiety and fear inducing situations 
(Ernst et al., 2007). AAS use during adolescence have been shown to affect different 
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neurotransmitters’ level such as serotonin, catecholamines (e.g., dopamine and 
norepinephrine), and GABA (Frahm et al., 2011). Overall, all these changes in 
neurotransmitters’ levels and brain organizations can increase the likelihood of behavioral 
and emotional disorders (Cunningham et al., 2013) since adolescents’ brains are still 
developing, they are more susceptible to the detrimental effects of AAS use (Bahrke et al., 
2000) and these harms may be permanent (Hildebrandt et al., 2014).  
1.3.4 Risks of AAS administration 
AAS can be administered orally or can be injected (van de Ven et al., 2020). The oral 
use of AAS has been uniquely linked to liver toxicity (Niedfeldt, 2018). It has been found 
that oral AAS users are more likely than injecting AAS users to use psychoactive substances 
and less likely to be informed about harm reduction and medical advice programs (van de 
Ven et al., 2020). People who inject drugs such as AAS are at risk of bacterial, fungal, and 
viral infections (Hope et al., 2013). A significant proportion of AAS users experience 
hepatitis B or C and HIV infections (Hope et al., 2013). The prevalence of HIV among AAS 
injectors is similar to that amongst psychoactive substance injectors (McVeigh & Begley, 
2017; Hope et al., 2016). Additionally, AAS are mostly produced in underground 
‘laboratories’ (Brennan et al., 2018) and sold on the illicit market. In addition, they are 
usually combined with various ancillary or supplemental substances, of which a large 
proportion are illegal in many jurisdictions (Evans-Brown et al., 2012). Indeed, an analysis 
of AAS products in a recent study indicated that the content of these product oftentimes does 
not match the label information (Smit et al., 2020). Hence, AAS may be contaminated with 
toxic biological or chemical matter and pathogens thereby causing additional and unexpected 
harms to AAS users (Smit et al., 2020; Weber et al., 2017).  
As indicated previously, AAS are often concurrently used with other licit or illicit 
drugs in order to enhance AAS effect, reduce the side effects of AAS, or for other purposes 
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(Dodge & Hoagland, 2011). Robust evidence indicates that polydrug use, denoting the 
concurrent use of multiple drugs or substances, is common among AAS users (Dodge & 
Hoagland, 2011; Molero et al., 2017; Sagoe et al., 2015a). In the 1990s, polypharmacy was 
mostly restricted to a small number of AAS combined with tamoxifen citrate and human 
growth hormone (i.e., human chorionic gonadotrophin) (Korkia & Stimson, 1993; Lenehan 
et al., 1996). A systematic review of quantitative studies on polypharmacy among AAS users 
indicated that the main supplementary or ancillary drugs they use are alcohol, cannabinoids, 
amphetamine, clenbuterol, cocaine, ecstasy, ephedrine, somatropin, insulin, thyroxine, 
selective estrogen receptor modulators, aromatase inhibitors, and human chorionic 
gonadotropin (hCG) (Hakansson et al., 2012; Molero et al., 2017; Zahnow et al., 2020). 
Moreover, non-AAS substances are also used to enhance performance, increase fat burn, 
counter the side effects of AA, and relax muscles after intense exercises. Polydrug use 
among AAS users has been shown to increase the risk of short- and long- term consequences 
of cross-drug interactions about which AAS users mostly are unaware of. Polypharmacy use 
can also lead to complicated medical responses in case of medical emergency and increase 
risk of adverse health effects (Molero et al., 2017; Nieschlag & Vorona, 2015). 
1.3.5 Harms to mental health 
AAS dependence 
Substance use disorders are among the most prevalent psychological disorders 
(Hoaken et al., 2012). In assessing the harms of substance use, people who are diagnosed 
with substance use dependence are known to be at greater risk of harm. Like other 
substances users, AAS users sometimes develop a dependence syndrome (Brower, 2002) 
which is also characterized by experiencing withdrawal symptoms and continued use despite 
experiencing adverse effects (Kanayama et al., 2009a; Brower, 2002). The medical, 
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cognitive, and psychological side effects of AAS use can be found in those users who fulfill 
criteria for AAS dependence syndrome (Kanayama et al., 2009a). It has been estimated that 
30% of AAS users experience a dependence syndrome (Kanayama et al., 2009a). Compared 
to nondependent users, AAS dependent users experience higher physical (Bjørnebekk et al., 
2020; Hauger et al., 2020), cognitive (Hauger et al., 2020; Vaskinn et al., 2020), emotional 
(Ip et al., 2012; Westlye et al., 2017), and psychosocial harms (Hauger et al., 2019, 2020). 
Particularly, AAS dependents are more likely to be involved in social conflicts and they 
show higher levels of aggression and antisocial behaviors compared to non-dependents 
(Brower et al., 1991; Hallgren et al., 2015; Hauger et al., 2019; Kanayama et al., 2009a). 
Like tobacco, alcohol, and opiates dependence, withdrawal symptoms such as decreased 
libido, depressed mood, and fatigue that arise from discontinuation are also observed among 
AAS dependents (Kanayama et al., 2009a). 
Mood disorders 
During the 1980s, some case and field studies began to report manic or hypomanic 
symptoms during AAS exposure and depressive symptoms, suicidal thoughts, and 
sometimes committed suicide upon AAS withdrawal (Choi et al., 1990). Not all AAS users 
experience manic or hypomanic symptoms (Clark & Henderson, 2003). However, among 
those who experience these symptoms, they appear within days or weeks after AAS use 
initiation. Another factor affecting the appearance of these symptoms is AAS dosage as they 
are more common among persons using more than 1000 mg of testosterone equivalent per 
week which is 15-20 times more than the testosterone a healthy male produce (Pope & Katz, 
1994). It has been suggested that the manic or hypomanic symptoms are associated with 
aggressive and violent behaviors among AAS users as well (Pagonis et al., 2006). 
Depressive symptoms, on the other hand, can appear within weeks of AAS withdrawal (Mey 
et al., 2018). These symptoms are also idiosyncratic and not all the AAS users experience 
24 
them upon withdrawal (Kanayama et al., 2020). Further, AAS use has been associated with 
increased sexual coercion and sexual motivation (Keleta et al., 2007). Several reports of 
severe psychiatric side effects including psychosis and extreme mood swings induce worries 
because these mental states are associated with violent harm to AAS users and/or others 
(Brower, 2009).  
1.4 Aggression 
Aggression can be explained as any forms of behavior that delivers harm (Ramírez, 
2010). Aggressive behaviors may be representative of psychological adaptations useful for 
survival with the goal of taking advantage when resources are limited and when harmful 
behaviors are more effective than negotiation (Buss, 1961; Haller & Haller, 2014). Further, 
aggression is intentional, and goal-centered with the recipient of the aggressive behavior is 
typically aversive towards it (Allen & Anderson, 2017). From an evolutionary perspective, 
aggression evolved as a means to gain and assert social status and in order to access or 
protect resources such as mates, food, territory and offspring (Buss, 1961; Darwin, 1871). 
Social psychologists define violence as severe form of aggression with serious physical 
and/or psychological harm as its main goal or consequence (Allen & Anderson, 2017; 
Piosiadlo et al., 2014). In this thesis, violence is perceived as a form of aggression and 
“aggression” is used in reference to both aggression and violence. Aggression can cause 
physical, emotional, and/or social harm (Allen & Anderson, 2017; Carroll & McCarthy, 
2018).  
In general, the bimodal classification of aggression identifies aggression as proactive 
aggression which is also called instrumental aggression and reactive aggression which is also 
called impulsive aggression (Haller, 2013). Proactive aggressive behaviors are mostly 
purposeful and offensive and have low emotional activity (Smeijers et al., 2018). The main 
motivation of proactive aggression is gaining an incentive through aggressive means and not 
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harming others (Smeijers et al., 2018). Proactive aggression involves low levels of guilt, 
emotional activity, and moral inhibition (Bussey et al., 2015; Euler et al., 2017; Nagy et al., 
2012). These characteristics help persons who deploy proactive aggression justify their 
behavior and achieve their goal (Smeijers et al., 2018). Proactive aggression results from 
excessive activation of reward circuits and same circuits are activated due to the rewarding 
effect of substance use (Bussey et al., 2015). Indeed, it has been shown that proactive 
aggressive behaviors are associated with drug addiction and substance use (Golden & 
Shaham, 2018). In addition to proactive aggression outlined above, aggression may also be 
affective (e.g., reflecting more immediate expressions of emotions; Ramírez, 2010). Reactive 
aggression is described as aggression that is impulsive, hostile, violent, and characterized by 
high emotional reactivity (Haller, 2013). Reactive aggression happens as a response to 
external threats or frustrating stimuli. The main motivation of reactive aggression is to 
remove the threat or stimuli and it is associated with a cortical control failure (Wrangham, 
2018).  
Another classification of aggression identifies aggressive behavior as direct and 
indirect aggression. Direct aggression includes physical and verbal acts of aggression and 
there is risk of serious physical, psychological and sexual harm when direct aggressive 
behaviors are severe (Wyckoff & Kirkpatrick, 2016). Indirect aggression includes hostile 
behaviors such as gossip in order to manipulate social situations (Björkqvist, 2018). The 
main motivation of indirect aggression is causing a psychological and/or social harm to the 
targeted person (Björkqvist, 2018).  
Aggression is used by all species and it is a normal and necessary component of 
social behavior (van Staaden et al., 2011). In general, an aggressive behavior is abnormal 
when it is goalless, or when its costs outweigh its benefits (World Health Organization; 
WHO, 2002; Vaughn et al., 2015). In humans, aggressive behaviors have decreased due to a 
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civilization process such as the centralization of the state and a change in cultural norms 
which has made some forms of aggression abnormal or illegal (Wrangham, 2018), for 
example, when the aggressive behavior is life threatening or it increases chances of future 
post-traumatic stress disorder or other types of psychiatric disease in victims and observers 
of the aggressive behavior. Aggression is predicted to threaten more lives by 2030 than the 
most prevalent diseases such as Alzheimers and breast cancer (World Health Organization, 
2010).  
1.4.1 Assessment of aggression 
Aggression in humans is assessed using laboratory behavioral measures, self-reports, 
and observer reports (Björkqvist et al., 1994; Buss & Perry, 1992; Chester & Lasko, 2019). 
As each form of assessment has strengths and limitations, triangulation and meta-analysis 
provide the best evidence of aggression assessment (Murad, Asi, Alsawas, & Alahdab, 2016; 
Warburton, 2014). Aggression measures used in investigating the relationship between AAS 
use and aggression are described next.  
Laboratory behavioral measures  
Laboratory behavioral measures assess aggression in laboratory settings (McCarthy 
et al., 2018). The Point Subtraction Aggression Paradigm (PSAP; Cherek, 1981) is a popular 
behavioral measure assessing aggression and competitiveness mostly in experimental 
settings (Geniole et al., 2017). The PSAP is an online computer game with the main goal of 
the game being winning over a fictitious opponent, gaining as many points as possible and 
exchanging the points for money at the end of the game. To provoke participants, the 
fictitious opponent starts taking points from the participants once they start collecting many 
points. At this point, participants are given three options: they can press the same 
predetermined key that they have been pressing from the beginning of the game, they can 
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press a different key that protects the points they already have for some time, or they can 
press a key that helps them steal points from the fictitious opponent. However, the researcher 
mentions to the participants that they are randomly assigned to a condition where they don’t 
get to keep the points they steal from the opponent. The main idea of provoking participants 
and later using the concept of stealing is that participants are put in a competitive 
environment with stealing as a means of harming (i.e., aggressive behavior) the opponent. 
Previous studies suggest that the relationship between AAS administration and aggression 
are stronger when assessed by behavioral aggression measures compared to self-report 
measures (Archer et al., 2005; Carré et al., 2017)  
Self-report measures 
Using self-report measures, respondents indicate their aggressive behaviors, emotions 
and cognitions typically via questionnaires. Self-report measures are popular in the 
assessment of AAS use and aggression. The Buss-Perry Aggression Questionnaire (BPAQ; 
Buss & Perry, 1992) is a self-report measure that assesses four different factors. These are 
anger (i.e., an aggressive affection linked to high psychophysiological activation and 
frustration), hostility (i.e., an aggressive cognitive attitude towards others), physical 
aggression, and verbal aggression (Sanz et al., 2010). The Buss-Durkee Hostility Inventory 
(BDHI; Buss & Durkee, 1975) is another widely used self-report measure for the assessment 
of cognitive (hostility) and affective (anger) aggression. This inventory consists of eight 
subscales. Two subscales assess two different types of hostility (resentment and suspicion), 
five subscales assess five different types of aggressive behaviors (assault, indirect 
aggression, irritability, negativism, verbal aggression, and guilt). Anger, the affective aspect 
of aggression, can also be assessed using the Multidimensional Anger Inventory (MAI; 
Siegel, 1986). The MAI assesses the frequency, duration, magnitude, mode of expression 
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(i.e., anger-in vs. anger-out, guilt, brooding, and anger-discuss), hostile-outlook, and range of 
anger-eliciting situations.  
Another widely used measure of aggression is the Profile of Mood States (POMS; 
McNair et al., 1992) that consists of 65 adjectives that describe temporary and discrete mood 
states. The POMS consists of six bipolar factors including anxious-composed, hostile-
agreeable, depressed-elated, unsure-confident, tired-energetic, and confused-clearheaded. 
The Aggressive Provocation Questionnaire (APQ; O’Connor et al., 2001) is also a self-report 
used in studies examining the relationship between AAS administration and aggression (e.g., 
O’Connor et al., 2002, 2004). The APQ consists of 21 vignettes that represent real 
provocative situations. Participants read the vignettes and report how they feel at that 
moment about each situation with the response alternatives being: angry, frustrated, and 
irritated. Next, participants report how they would react in each situation with response 
alternatives being: avoiding, no response, getting angry, showing assertive behavior, and 
showing direct aggression.  
Observer reports  
Observer-report measures of aggression (e.g., the Partner Aggression Questionnaire: 
AQ-P; O’Connor et al., 2001) are typically adapted versions of self-report measures (e.g., the 
Aggression Questionnaire: AQ; Buss & Perry, 1992). They are used to decrease possible 
problems associated with self-reports (e.g., social desirability response bias) and for 
obtaining an evaluation of the subject’s aggressive behaviors and emotions from their 
partner, acquaintance or other observer (O’Connor et al., 2004). Observer report aggression 
measures are usually completed in a private room in the subject’s absence. It has been shown 
that observer reports provide different information than self-reports in the same study due to 
differences in perspective (Abernethy, 2015). Although observer-report measures of 
aggression do not take into account internal processes such as the motives and intentions of 
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the subject, they are useful for obtaining information about the aggressive behavior, 
emotions, and personality of a subject (Mount et al., 1994; O’Connor et al., 2001). 
1.5 Substance use and aggression 
Substance use and aggression frequently co-occur (Pihl & Sutton, 2009; Tomlinson 
et al., 2016). There is robust evidence on the association between substance use (e.g., 
alcohol, psychostimulants, opioids, and hallucinogens) and aggression in adolescence, 
adulthood, as well as in intimate relationships (Tomlinson et al., 2016). These associations 
present important legal, social, and psychological dilemmas (Hammersley, 2011). Further, 
since substance use disorders are among the most prevalent mental disorders, the association 
between substance use and aggression induces serious concerns (Hoaken et al., 2012). 
Overall, studies on the relationship between substance use and aggression have found 
differing unidirectional and bidirectional associations between these two behaviors. Studies 
supportive of a unidirectional relationship indicate that substance use predicts aggression 
and/or aggression predicts substance use (Leober et al., 1998; Scal et al., 2003). On the other 
hand, studies supporting a bidirectional relationship suggest that these two behaviors 
reinforce each other mutually (Huang et al., 2001). There is also available evidence that does 
not support significant relationships between substance use and aggression in either direction 
(Brook et al., 1995).  
1.6 AAS use and aggression 
The most well-known psychological adverse effect of AAS use among the general 
population is lack of impulse control, hostility, and high levels of aggressive and violent 
behavior sometimes referred to as “roid rage” or “steroid rage” (Nelson, 1989; Pope & Katz, 
1987; Taylor, 1987). In the 1940s, Arnold A. Berthold castrated developing male chicken 
and observed that they stopped developing secondary sexual characteristics and aggressive 
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behavior (Berthold & Quiring, 1944). Later, Berthold transplanted testes taken from another 
male chicken to the castrated male chicken and noticed that the chicken regained their 
secondary sexual characteristics. This study and later animal studies in which animals were 
castrated (Nelson et al., 1989; Takeshita et al., 2017) suggested that testosterone may also 
modulate aggressive behavior in humans. In the 1980s, there was an emergence of case 
studies (Pope & Katz, 1987; Tragger, 1988) linking AAS use to aggression particularly 
homicide and near-homicide with an accumulation of case studies over the years (Choi et al., 
1990; Khoodoruth & Khan, 2020; Papazisis et al., 2007; Pope & Katz, 1990; 1994). In one 
case study, a man with a complex history of mental health and alcohol use murdered and 
dismembered his wife after using AAS for two weeks (Seppänen & Eronen, 2016). It must 
be noted that case studies are restricted in their nature and therefore lack external validity 
and do not enable causal inferences.  
It has been suggested that compared to non-AAS-users, AAS users experience 
increased aggression and hostility over time (Choi et al., 1990). Moreover, it has also been 
shown that after 6 to 14 weeks of AAS use, recreational sportspeople report higher feelings 
of aggression towards objects (especially while training) and verbal aggression (Parrott et al., 
1994). AAS users do not only have an increased risk of premature death but also have an 
increased risk of violent death compared to people who use other types of drugs (Hall et al., 
2005). Case and survey studies also describe many male users with no history of 
psychological disorders or criminal background who were convicted of a violent crime or 
committed murder during AAS exposure (Christoffersen et al., 2019; Hall et al., 2005; Pope 
et al., 2014a). Numerous cross-sectional survey studies indicate that AAS use is associated 
with aggression particularly when concurrently used with alcohol (Jenssen & Johannessen, 
2015; Sagoe et al., 2016a; van Amsterdam et al., 2010). In one cross-sectional study 
(Lundholm et al., 2015), lifetime AAS use had a strong positive association with criminal 
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conviction but this association diminished after adjusting for polydrug use. Some qualitative 
studies have also provided evidence from AAS users in which they have self-reported 
increased aggressiveness and willingness to fight after AAS exposure (Skårberg et al., 2008; 
Bates & McVeigh, 2016, Bahri et al., 2017). In a study of monozygotic twins, it was found 
that the twin who administered AAS became more aggressive, hostile, anxious, and paranoid 
compared to the twin who did not use AAS (Pagonis et al., 2006).  
The evidence base on AAS use and aggression strongly relies on an experimental 
approach since the main goal in laboratory studies is to establish causation. Experimental 
animal studies on the AAS use and aggression relationship indicate robust positive effects 
with the AAS type, age of ingestion, the environmental context, and species as moderators 
(Bronson, 1996; Carrillo et al., 2011; Clark & Henderson, 2003; Cunningham & McGinnis, 
2008; Onakomaiya et al., 2014). For example, although male rats are not normally 
aggressive towards female rats, when exposed to AAS, they show aggressive behaviors 
towards ovariectomized females (Cunningham & McGinnis, 2006). These behaviors are 
augmented when nandrolone is administered on adolescent male rats (Kalinine et al., 2014). 
Animal studies of female rodents also indicated that they became more behaviorally 
aggressive after AAS administration (Oberlander & Henderson, 2012). 
However, results from human placebo-controlled randomized studies show an 
inconsistent association between AAS administration and aggression. Findings comprise 
negative (Björkqvist et al., 1994), positive (Panagiotidis et al., 2017; Wagels et al., 2018) 
and non-significant results (Tricker et al., 1996). Thus, it is still not clear whether aggression 
is an antecedent or consequence of AAS use (Dunn, 2015; Lundholm et al., 2015) and this 
relationship presents an ongoing serious concern (Christoffersen et al., 2019; Hoaken et al., 
2012; McVeigh & Begley, 2017; McVeigh et al., 2020). 
1.7 Theoretical associations of AAS use and aggression  
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Various theories have been proposed in order to highlight the relationship between 
use of AAS and aggression. These theories present biological, evolutionary, psychosocial 
and cognitive perspectives and altogether provide a deeper explanation of the link between 
AAS use and aggression. 
1.7.1 The dual-hormone hypothesis 
The dual-hormone hypothesis (Mehta & Josephs, 2010) was initially proposed to 
explain the relationship between testosterone and status-seeking related behaviors such as 
aggression and dominance. The dual-hormone hypothesis proposes that in status-seeking 
contexts, testosterone levels (which are implicated in aggression and dominance) are usually 
higher, and cortisol levels (which are implicated in submissive behavior and lower anxiety 
levels) are lower (Denson et al., 2013; Eisenegger et al., 2010). It has been shown that 
testosterone and cortisol levels measured at the same time of the day are stable (Mehta & 
Josephs, 2010). However, their levels change when exposed to status-seeking contexts 
(Mehta & Prasad, 2015). The dual-hormone hypothesis suggests that an increase in 
testosterone level is associated with increased aggression only when the level of cortisol is 
low (Mehta & Josephs, 2010). Using the dual-hormone hypothesis, researchers have found 
that the balance between testosterone and cortisol levels can be predictive of proactive and 
reactive aggressive behaviors (van Honk et al., 2010). 
The dual-hormone hypothesis has been supported by cross-sectional studies using 
aggression measures in different age groups (Mehta & Prasad, 2015). For example, it has 
been shown that adolescent prisoners’ aggressiveness is positively associated with their 
testosterone levels and negatively associated with their cortisol levels (Debbs et al., 1991). 
Results from clinical studies using samples with conduct disorder and clinical psychopathy 
as well as healthy persons also support the dual-hormone hypothesis (Glenn et al., 2011; 
Mehta & Josephs, 2010). However, results from experimental studies does not consistently 
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support this hypothesis (Denson et al., 2013; Geniole et al., 2011). Moreover, a recent meta-
analysis that tested the interaction of testosterone and cortisol levels on status-seeking 
behaviors found a small significant effect and provided some support for the dual-hormone 
hypothesis (Dekkers et al., 2019). 
1.7.2 The challenge hypothesis 
The challenge hypothesis (Wingfield et al., 1990) was originally proposed to explain 
the relationship between testosterone and aggression in monogamous birds (Wingfield et al., 
1990). When males need to guard their mate and offspring from rivals or mark their territory, 
testosterone levels increase, facilitating aggressive behavior. However, in situations where 
males need to express parental care, their testosterone level and aggressive behavior 
decreases (Wingfield et al., 2000). It has been suggested that since maintaining elevated 
testosterone levels is cost inflicting (e.g., decreased paternal care, decreased immune 
function, elevated risk of death/injury), the endocrine system have been evolutionary wired 
to modulate testosterone level according to different social and environmental contexts 
(Wingfield et al., 2000).  
Since 1990, human studies have been examining the challenge hypothesis to 
investigate whether the testosterone-aggression relationship in humans can be explained by 
this evolutionary-based hypothesis (Carré & Archer, 2018). Consistent with the challenge 
hypothesis, numerous studies have supported the notion that intrasexual competition and 
social status seeking increases testosterone and aggressive behaviors (Gray et al., 2020). 
Further, it has been shown that testosterone increases in competitive contexts, which is 
followed by willingness to compete and increased aggression (Zilioli & Bird, 2017). The 
challenge hypothesis has been supported by studies on prenatal and adolescents’ 
development. Studies on postnatal (i.e., birth to 6 months) testosterone levels have suggested 
that exposure to testosterone is associated with higher rates of aggression and risky 
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behaviors in unpredictable environments (Kuzawa et al., 2010). Thus, according to the 
challenge hypothesis, the association between acute changes in testosterone and aggression 
is context dependent (Carré & Archer, 2018). In light of the challenge hypothesis, numerous 
human studies have suggested that acute testosterone change can lead to aggressive 
behaviors in competitive interactions and/or socially provocative contexts (Carré & 
Olmstead, 2015). 
1.7.3 Life history theory 
Evolutionary psychologists apply life history theory (LHT) to understand adaptive 
and maladaptive human social behaviors (Del Giudice, 2018). According to this theory, 
human beings invest in different survival and reproductive strategies based on variability in 
environmental conditions they are evolved in (Hill & Kaplan, 1999). A harsh and 
unpredictable environment can promote a fast life history which is characterized by 
increased risky, short-term, and opportunistic behaviors as well as earlier sexual debut and 
substance use (Figueredo et al., 2006). Individuals who adopt a fast life history strategy 
believe that “life is too short not to risk”, and “future is unpredictable, uncontrollable, and 
unknown”. These beliefs are basically immediate survival focused (Mittal & Griskevicius, 
2014) and motivate individuals to engage in risky behaviors such as substance use (Hill et 
al., 1997).  
The evolutionary rationale for individuals who apply fast life history strategies is that 
these behaviors are adaptive and increased survival and reproductive fitness in the 
evolutionary past especially among individuals that could take advantage of immediate 
opportunities with short-term benefits and long-term costs (Del Giudice, 2009). For 
example, engaging in risky behaviors such as substance and alcohol use as a result of peer 
pressure can result in more popularity among peers in the short-term but, in the long-term, 
they result in various physical and psychological harms (Belsky et al., 2012).  
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Overall, it has been shown that substance use and aggressive and antisocial behaviors 
are byproducts of adaptations to harsh and unpredictable environmental conditions such as 
lower family cohesion and greater family hostility (Nation & Heflinger, 2006; Richardson & 
Hardesty, 2012). LHT has been used in explanations of the associations between substance 
use and impulsivity (Brumbach et al., 2009), psychosocial stress and insecure attachment 
(Del Giudice, 2009), intimate partner aggression (Figueredo et al., 2011, 2018), and 
aggression (Figuerdo et al., 2018). In the context of LHT, the association between AAS use 
and aggression can be explained as a byproduct of adaptations to harsh and unpredictable 
environmental conditions such as the bodybuilding context and security workplace (e.g., 
night club door, police and military) where displaying an imposing macho physique may be 
advantageous (Givens et al., 2016; Hoberman, 2017; Simoni & Huhtaniemi, 2017).   
1.7.4 Social learning/cognitive theory 
In 1971, Bandura proposed the social learning theory which suggests that a behavior 
is learnt by observing and modelling behaviors and attitudes of significant others (Bandura, 
1986). Bandura referred to this type of learning as vicarious learning. Through vicarious 
learning, a person observes the model’s behavior, cognitively maintains the observed 
behavior, and when motivated executes the learnt behavior (Bandura, 1986). Bandura (1986) 
further suggested that the environment plays a very important role in learning and later 
exhibiting maladaptive behaviors such as substance use and aggression (Conger & Rueter, 
1996). Numerous studies on acquisition of maladaptive behaviors during childhood and 
exhibiting them later during adolescence and in adulthood have supported the SLT (Egan et 
al., 1998; Weiss et al., 1992).  
Bandura (1986) integrated the prominent role of personal influences in his theory by 
introducing a conceptual framework termed “triadic reciprocality” or “triadic reciprocal 
determinism” (see figure 1) into his initial theory and rearticulated SLT as social cognitive 
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theory (SCT). Triadic reciprocality includes three sets of factors: behavioral, environmental, 
and personal factors that interact together to influence learning and maintaining of behavior 
(Bandura, 1986). In the context of SCT, aggression can be explained as a product of the 
reciprocal interaction of behavioral factors (AAS use), environmental factors (the 
bodybuilding and security contexts), and personal factors (lack of self-regulation, status 
seeking, and impulsivity) as supported by a meta-synthesis of qualitative studies on AAS use 
initiation (Sagoe et al., 2014b).  
 
 
Figure 1: Triadic reciprocal determinism 
 
1.7.5 Problem behavior theory 
Jessor and Jessor (1977) proposed problem behavior theory (PBT) which asserts that 
there are common risk and protective factors underlying problem behaviors such as 
substance use, aggression, delinquency, and crime (Jessor, 2016). According to PBT, risk 
factors increase the likelihood of engaging in problem behaviors whereas protective factors 
diminish the likelihood of engaging in problem behaviors (Jessor, 2016; Jessor & Turbin, 
2014). In PBT, the co-occurrence of multiple problem behaviors has been termed problem 
behavior syndrome (PBS; Willoughby et al., 2004). PBS suggests that engaging in one 
problem behavior such as substance use is associated with engagement in other problem 
behaviors such as aggressive and violent behaviors (Miller et al, 2005; Sagoe et al., 2016a). 
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In explaining the organization and patterning of PBS, Jessor (2016) delineated a social 
ecology of problem behaviors in that problem behaviors are learnt and performed together.  
In 1991, Jessor reformulated PBT and introduced three psychosocial explanatory 
systems in the theory: 1) perceived environment system which includes proximal (e.g., 
awareness of friends influence) and distal (e.g., positive relations with adults) social factors, 
2) personality system including motivational-instigation (e.g., value on academic 
achievement), personal belief (e.g., social criticism), and personal control (e.g., religiosity), 
and 3) behavioral system including conventional (e.g., church attendance) and deviant (e.g., 
poor school achievement) behaviors. These psychosocial protective factors and risk factors 
can predict involvement in problem behaviors such as substance use, aggression, 
delinquency, and early sexual intercourse (Jessor, 2018). PBT has been one of the most 
influential theories of deviant behaviors the last two decades (Jessor, 2016).  
PBT has been empirically supported in the AAS use literature with numerous studies 
finding associations between AAS use and contemplation on one hand and aggression as 
well as use of narcotics, alcohol, and marijuana, risky sexual behavior, anti-social behaviors, 
and delinquency (Farrell et al., 2020; Hallgren et al., 2015; Miller et al., 2005; Pallesen et al., 
2006; Sagoe et al., 2016a; Wichstrøm, & Pedersen, 2001) on the other. Particularly, a cross 
sectional study indicated that aggression is a risk factor of adolescents’ AAS use 
contemplation (Sagoe et al., 2016a). Other recent evidence suggests that the likelihood of 
engaging in school and teen dating aggression is higher among adolescent AAS users 
compared to nonusers (Elkins et al., 2017; Ganson & Cadet, 2019). Additionally, it has been 
shown that adolescents who were in the proxy of AAS milieu, but did not use them, were 
also more likely to involve in violent behaviors than those who were not in the proxy of such 
environments (Pedersen et al., 2001).   
1.8 Aims 
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1.8.1 Thesis aims 
From the foregoing literature review, it can be deduced that the association between 
AAS use and aggression is still unclear. Particularly, the association between AAS use and 
aggression remains inconsistent in human randomized controlled trials (RCTs). Additionally, 
although aggression and psychological distress seem to be major behavioral outcomes of 
AAS use, no previous study has examined subgroups of AAS users based on their aggression 
and psychological distress profiles. Here, female AAS users seem particularly to be 
understudied and it is further unclear if there are unobserved intersex differences. Finally, 
there is a dearth of longitudinal research on the correlates, particularly physical and verbal 
aggression, of AAS use and intent in adolescence and emerging adulthood.  
This thesis aimed to contribute to the evidence base on AAS use and aggression by: 
(a) systematically reviewing and quantitatively synthesizing results from human RCTs on 
AAS administration and aggression, (b) examining subgroups of aggression and 
psychological distress in AAS users as well as investigating sex differences in the 
subgroups, and (c) examining the longitudinal correlates, with emphasis on the role of 
physical and verbal aggression, of AAS use and intent in adolescence and emerging 
adulthood. In this thesis, three studies were conducted to address the aforementioned gaps in 
the literature. 
1.8.2 Aims of Study 1 
Study 1 aimed to synthesize and integrate findings from human placebo-controlled 
RCTs using systematic review and meta-analysis to examine the effect of AAS 
administration on self-reported as well as observer-reported aggression in healthy persons. 
1.8.3 Aims of Study 2 
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Study 2 sought to identify subgroups of male and female AAS users based on their 
physical aggression, verbal aggression, anger, hostility, and psychological distress profiles 
and whether these subgroups can be applied to both sexes.  
1.8.4 Aims of Study 3 
Study 3 aimed to longitudinally investigate the associations between aggression, sex, 
living situation, grade point average, AAS, alcohol, cigarette and snus use as well as 
depression and anxiety symptoms and AAS use intent from age 18 to 19, highlighting the 
role of physical and verbal aggression. Another aim was to investigate the prevalence of 




2.1.1 Measures of Study 2 
Demographics 
AAS users who participated in the study were asked to indicate their age, sex, weight 
(kg), and height (cm). The educational level of participants was assessed by means of a 
single item: “What is your highest level of education completed?”. Response alternatives 
included: high school (1), diploma (2), technician (3), bachelor (4), master (5), and PhD (6). 
Marriage status was assessed with the question: “What is your marital status?”. For the 
Iranian setting, response alternatives were: single (0) and married (1).  Finally, participants 
indicated their job status by responding to the question “What is your job status?”. Response 
alternatives for this question consisted of: full time (1), part time (2), self-employed (3), 
jobless (4), student (5), and other (6). 
Sports participation and weight training 
Participants indicated their involvement in sports based on the following response 
alternatives: competitive sport (1), recreational sport (2), competitive bodybuilding (3), and 
recreational bodybuilding (4). They also answered a question about how many years in total 
they have been regularly engaged in weight training and how many times per week they 
trained with weights.  
AAS use and type 
Current AAS use was assessed with the question: “Do you currently use anabolic-
androgenic steroids?” with ‘yes’ scored ‘1’ and ‘no’ scored ‘0’. Participants also indicated 
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the type of AAS they used. Response alternatives were: Anadrol (Oxymetholone), Anavar 
(Oxandrolone), Deca-Durabolin (Nanrolone decanoate), Depo-Testosterone, Dianabol 
(Methandrostenolone), Durabolin, Equipoise (Boldenone), Finajet (Trenbolone), Maxibolim 
(Ethylestrenol), Methyltestosterone, Oxandrolone, Primobolan, Steroid cocktail, Sustanon, 
Testosterone, and Stanozolol (Winstrol). There was also an open-ended section for 
participants to indicate any other AAS they had used. Finally, for the assessment of AAS use 
duration, participants indicated how many years they had been using AAS regularly.  
Aggression 
Physical and verbal aggression were assessed using the physical aggression and 
verbal aggression subscales of the Short-Form Buss-Perry Aggression Questionnaire 
(BPAQ-SF; Diamond & Magaletta, 2006). The physical aggression subscale consists of four 
items (e.g., “I have trouble controlling my temper”) while the verbal aggression subscale 
contains three items (e.g., “My friends say that I’m somewhat argumentative”). Items for 
each subscale are answered on a five-point response scale with ‘very unlike me’ scored ‘1’ 
to very like me’ scored ‘5’. Higher scores on each subscale suggest higher propensity toward 
the corresponding type of aggression.  
Psychological distress 
Symptoms of anxiety and depression were assessed using the Hospital Anxiety and 
Depression Scale (HADS; Montazeri et al., 2003; Zigmond & Snaith, 1983). HADS consists 
of 14 items. Depression symptoms are assessed by seven items (e.g., “I feel as if I am slowed 
down”). Anxiety symptoms are also assessed by seven items (e.g., “I feel restless as I have to 
be on the move”). Items are answered on a four-point response scale. However, response 
alternatives are unique for each item. A composite score of anxiety and depression was 
computed to indicate psychological distress of participants. The computation of a composite 
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HADS score is in line with previous studies in which a superior factor loading of one general 
factor has been shown (Kjærgaard et al., 2014).  
2.1.2 Measures of Study 3 
Demographics 
Participants indicated their sex with being male scored as 0 and being female scored 
as 1. They also indicated their grade point average (GPA). Additionally, participants were 
asked about their living situation with the question: “Who do you live with?”. Response 
options were: live with both parents (1), live with only one of the parents (2), shuttling 
between parents (3), live alone (4), live in a household/dormitory (5), and other (6).  
Use of AAS, snus, and cigarette 
Participants answered whether they had used AAS in the past 12 months. “Yes” responses 
were scored 1 and “no” responses scored 0. They were also asked about how often they 
smoked during the last month with ‘every day’ scored ‘2’, ‘less than every day’ scored ‘1’, 
and ‘not at all’ scored ‘0’. They also specified how often they used snus, using the same 
response alternatives as for smoking as above.  
AAS use intent 
The Intent to Use AAS Scale (IUAS; MacKinnon et al., 2001), was used to assess 
AAS use intent. IUAS consists of five items measured on a five-point response scale; 
‘strongly disagree’ scored ‘1’ to ‘strongly agree’ scored ‘5’. Higher scores on the IUAS 





Aggression was examined using the Short-Form Buss-Perry Aggression 
Questionnaire (BPAQ-SF; Diamond & Magaletta, 2006; Samani, 2008). This questionnaire 
consists of four subscales. These are physical aggression, verbal aggression, anger, and 
hostility. Physical aggression and verbal aggression subscales are defined in Measures of 
Study 2 section. The anger subscale consists of two items (e.g., “I sometimes feel like a 
powder keg ready to explode”) and the hostility subscale consists of three items (e.g., “I 
wonder why sometimes I feel so bitter about things”). Items are answered on a five-point 
response scale ranging from very unlike me (1) to very like me (5).  
Anxiety and depression  
Psychological distress was assessed using the HADS (Montazeri et al., 2003; 
Zigmond & Snaith, 1983). Subscales and their response alternatives are explained in 
Measures of Study 2 section. A score of 8 or higher on each subscale denotes mild anxiety 
and depression (Carroll et al., 1993). The time frame for the HADS is the past week. 
Alcohol misuse  
The Alcohol Use Disorder Identification Test-Consumption (AUDIT-C; Bush et al., 
1998) is a short instrument with three items and it was used to assess alcohol misuse. Items 
include: “How often do you drink alcohol?”, “How many units of alcohol (a drink, a glass of 
wine, a shot, and/or small bottle of beer?”, and “How often do you drink six or more units of 
alcohol at once?”. Response alternatives are unique for each item. AUDIT-C’s items are 
answered on a five-point response scale ranging from never (0) to four times or more per 
week (4). A total score is calculated with a score of 5 or higher indicating alcohol misuse.  
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2.2 Samples and procedures 
2.2.1 Included studies and procedure of Study 1 
Search strategy and inclusion criteria 
MEDLINE, PsycINFO, ISI Web of Science, ProQuest, Google Scholar, and 
Cochrane Library were systematically searched for research literature with no time 
constraints. The latest literature search was conducted on 31st December 2019. In 2020, ad 
hoc searches were conducted to corroborate comprehensiveness. Keywords for the literature 
search are presented in Appendix A.  
 Studies that met the following inclusion criteria were included: studies that (a) 
investigated the effects of AAS administration on aggression among healthy persons, (b) 
were randomized controlled trials (RCTs), (c) assessed aggression utilizing valid aggression 
measures, and (d) were published in English. From a total of 30,407 hits, 3,772 were 
duplicates and 7,647 were grey literature. Of the remaining 18,988 hits, 18,752 were 
removed after screening by title and abstract. Thus, 238 full-text articles were retrieved for 
further evaluation. Of the remaining records, 226 full-text records comprised animal 
experimental studies, cross-sectional, case studies, and narrative reviews and were therefore 
removed at the eligibility assessment stage of the selection process leaving 12 studies that 
passed the inclusion criteria and were included in the meta-analysis. The literature search 
was conducted in adherence to the guidelines and recommendations of Preferred Reporting 
Items for Systematic Reviews and Meta-Analysis (PRISMA; Moher et al., 2009). 
Data extraction 
Data on study authors, country, design (e.g., double-blind), sample type (i.e., healthy 
males), sample size, age (range, M ± SD), study groups (e.g., placebo group), AAS type, 
AAS dose, AAS administration mode (e.g., injection), study duration, assessment type (e.g., 
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self-report), aggression measure, and results were extracted from the final identified hits 
using a standardized data extraction sheet form by two reviewers independently. The two 
reviewers discussed any possible discrepancies in data extraction and reached consensus.  
2.2.2 Sample and procedure of Study 2 
Sample 
A total of 206 current AAS-using weightlifters took part in this study (females = 
58.30%). Participants’ age ranged from 14 to 56 with a mean age of 26.89 (SD = 7.12) years.  
Procedure 
This study was a cross-sectional survey and self-report questionnaires were used to 
collect data. Participants were recruited from training centers and sports supplement stores in 
Tehran, Iran. Eligibility criteria for participation in this study were: (a) being a current 
weightlifter, and (b) having used AAS regularly for at least the past six months before data 
collection. Participation was voluntary and anonymous, and all participants provided oral 
consent prior to data collection. No incentive or compensation were given to participants 
upon partaking in the study. Data were collected in June 2019. The study was conducted in 
accordance with the Declaration of Helsinki. Alzahra University in Tehran, Iran provided 
ethical approval for the study.  
 
2.2.3 Sample and procedure of Study 3 
Sample 
Participants were pooled from an initial sample of 3000 17-year-olds that were 
randomly selected from the Norwegian Population Registry in 2012 (wave 1). In wave 1, 
2055 (female = 53.0%) participants completed the questionnaires (response rate = 70.4%). In 
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2013, when the participants were 18 years old, they were contacted again to complete the 
questionnaire for wave 2. This time, of the 2055 participants from wave 1, a total of 1333 
persons (females = 58.9%, response rate = 64.9%) completed the questionnaire. The last 
wave (wave 3) was collected in 2014 when the participants entered adulthood (19 years old). 
A total of 1277 of the participants returned completed questionnaires (females = 61.7%, 
response rate = 62.1%). 
Procedure 
  The study was a longitudinal survey by means of a self-report questionnaire. 
Participants were selected from the Norwegian National Population Registry in 2012 using a 
random selection method. They received postal invitations containing the following material:  
an information sheet explaining the purpose of the study, information about the 
confidentiality of the study, information about compensation (NOK200,  €25), and the 
questionnaire. Answering the survey was regarded as providing informed consent. 
Participants were provided with a pre-paid envelope for returning completed questionnaires. 
In 2013, the Intent to Use AAS Scale (IUAS; MacKinnon et al., 2001) was included in the 
questionnaire and same participants from wave 1 were contacted to complete the 
questionnaire again for wave 2. The same process was repeated in 2014 (wave 3). The 
Regional Committee for Medical and Health Research Ethics in South East Norway 
provided ethical approval for the study (REK 2012/914).   
2.3 Statistical procedures 
2.3.1 Statistical analysis in Study 1 
The analysis examined the effects of AAS administration on self-reported aggression 
in RCTs under the random-effects model. Moreover, three separate analyses were conducted 
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to examine the effects of high-dose (over 500 mg) AAS administration, long-term (from 3 
days to 14 weeks) AAS administration, and acute AAS administration on self-reported 
aggression. Analysis was also conducted to examine the effect of AAS administration on 
observer-reported aggression. Due to the small number of included studies, analyses of the 
effects of acute (k = 4) and high-dose AAS administration (k = 5) on self-reported 
aggression, as well as the effect of AAS administration on observer-reported aggression (k = 
3) were conducted using a fixed-effect model (Borenstein, 2009). Additionally, analysis of 
the effect of long-term AAS administration (k = 7) on self-reported aggression was 
conducted under a random-effects model. Finally, using meta-regression analysis, the effect 
of AAS dose on self-reported aggression was examined.  
Some of the studies included in the current meta-analysis used multiple aggression 
measures. In order to combine scores from multiple measures, instruments should be highly 
correlated and measure the same construct (Gleser & Olkin, 2009). Here, the analysis 
combined scores from different aggression measures and calculated a final effect size 
estimate from each study in the analysis as recommended (Gleser & Olkin, 2009). Using 
previous validation studies on aggression instruments, a correlation of 0.6 was used to 
provide the best estimates of study variance and corresponding confidence intervals (Gleser 
& Olkin, 2009). For crossover studies, previous longitudinal studies on aggression were used 
to estimate a correlation between aggression scores over time (Krahé & Möller, 2010). An 
average correlation of 0.5 between aggression measures over time was estimated to provide 
optimal estimates of effect sizes. For studies with multiple groups (i.e., a passive control 
group, a placebo group, and a treatment group), only data from the placebo and treatment 
groups were used. 
The fixed-effect model assumes that all factors that could affect the effect size are the 
same in all the included studies. Hence, the common (true) effect size is assumed to be the 
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same in all the included studies. In contrast, the random-effects model assumes that the 
variability in effect size estimates can be decomposed into two parts: heterogeneity due to 
random population effects and sampling variance (Borenstein, 2009). For the assessment of 
heterogeneity, the Q-statistic and the I2 statistic were used. The Q-statistic is calculated as 
the weighted sum of squared differences between individual study effects and the pooled 
effect across studies. The I2 is a percentual statistic (0-100) that describes the proportion of 
the observed variance across studies that reflects real differences in effect size with 0% 
indicating no heterogeneity, 25% indicating low heterogeneity, 50% indicating moderate 
heterogeneity and 75% suggesting high heterogeneity (Higgins et al., 2003). Moreover, 
Duval and Tweedie’s (2000) trim and fill method, and Orwin’s (1983) fail-safe N were 
utilized to examine publication bias. The Cochrane risk of bias tool (Higgins et al., 2003) 
was used to assess the risk of each study. The meta-analysis was preregistered in 
PROSPERO (CRD 42019117834). The Comprehensive Meta-Analysis software version 
3.3.070 (Borenstein et al., 2014) was utilized to conduct the meta-analysis and meta-
regression.  
2.3.2 Statistical analysis in Study 2 
Standard descriptive statistics were used to determine characteristics of the sample. A 
multilevel latent class analysis (MLCA; Lazarsfeld & Henry, 1968) was conducted to 
determine how male and female AAS users can be categorized based on their direct (i.e., 
physical and verbal aggression), indirect aggression (i.e., anger and hostility), and 
psychological distress levels, and whether the identified classes can be applied to both sexes. 
MLCA is a model-based clustering method that uses the manifest variables found in a survey 
to identify unobserved classes of response patterns. Different model fit criteria are used in 
order to determine the number of classes. The likelihood-ratio chi-square (L2) criteria is used 
as a standard measure of the difference between observed and expected frequencies in the 
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model. A significant L2 indicates that the model does not fit the data. The Bayesian 
Information Criterion (BIC; Schwarz, 1978) penalizes models with larger numbers of factors 
and is one of the most used information criteria for estimating the number of classes (Collins 
& Lenza, 2010). Models with lower BIC values have a better fit to the data (Kankaraš et al., 
2010). Finally, the quality of the classification was examined using entropy R2 and total 
proportion of adjacent classification error. 
Additional analysis examined whether the identified subgroups of AAS users could 
be applied to both sexes. A MLCA assumes the presence of three types of variables: 
observed variables (here direct and indirect aggression and psychological distress), 
unobserved variable(s) that accounts for the relationship between the observed variables, and 
a grouping variable (here sex) which is a categorical manifest variable that can be associated 
with both the observed variables and the latent class(es). The analysis aimed to examine 
whether class-specific conditional response probabilities (class structures) were equivalent 
across male and female AAS users therein defining measurement equivalence. When 
comparing latent classes across groups, the analysis imposes across-group equality 
restrictions on specific sets of model parameters which leads to three different levels of 
homogeneity or measurement invariance.  
First, when all the model parameters are set to be equal across the grouping variable 
and the latent classes have the same structure in each group, the model is homogeneous. 
Here the direct effect of the grouping variable on the observed variables and the interaction 
of the grouping variable with the latent classes are eliminated from the model. Second, when 
there are no restrictions on both the direct effect of the grouping variable on the observed 
variables and the effect of the interaction of the grouping variable with the latent classes the 
model is heterogeneous. Third, interaction effects exist when the grouping variable differs in 
the effects of latent classes on the observed variables whereas the direct effect exists when 
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differences in scores of grouping variable respondents are not related to differences in a 
given latent class (Kankaraš et al., 2010). If some of these effects are restricted to be equal 
across all groups while some of the effects are kept in the model, the model is partially 
homogeneous. The present study examined measurement invariance by conducting 
homogeneous, partially homogeneous, and heterogeneous multigroup latent class analyses 
with sex as the grouping variable. To analyze the invariance of each observed variable, the 
direct effect of the grouping variable was added onto each indicator in the partially 
homogeneous model. 
Finally, the analysis compared the models in order to choose the best model fit for the 
data. For this purpose, L2 differences between two consecutively nested models was used. 
The fully restricted homogeneous model served as the reference model for this comparison. 
When moving from the homogeneous model to the heterogeneous model, if the difference in 
L2 between the two consecutive nested models (i.e., one model is obtained from a general 
model by imposing complex and decreasing homogeneity on the former) is significant, the 
best-fitting model is the one with more heterogeneity and less degrees of freedom 
(Schermelleh-Engel et al., 2010). After selecting the best model for the data, class 
proportions for each group were examined. Here, participants’ likelihood of belonging to a 
subgroup was based on the proportional assignment rule (Goodman, 2007; Magidson & 
Vermunt, 2002). The association between sex and group membership was examined using 
the Walt test. Descriptive analyses were conducted using RStudio version 1.1.463 (RStudio, 
Inc), and the LCA was performed using advanced LatentGOLD 5.1 (Vermunt & Magidson, 
2016). 
2.3.3 Statistical analysis in Study 3 
Standard descriptive statistics were used to determine frequencies of females and 
males, past year AAS use, living situation, past month cigarette use, past month snus use, 
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and alcohol misuse in both waves. Mean, standard deviation and log-transformed skewness 
and kurtosis scores for intent to use AAS, physical aggression, verbal aggression, and grade 
point average were calculated. Correlations between the independent variables at both waves 
were also estimated using Pearson product-moment correlations, point-biserial correlations, 
and phi coefficients. Mean differences of physical aggression, verbal aggression, intent to 
use AAS from wave 2 to wave 3 were examined using paired t-test.  
The influence of the independent variables (i.e., intent to use AAS ate wave 2, 
physical aggression and verbal aggression at wave 2, sex, living situation, grade point 
average, last year AAS use, alcohol misuse, last month cigarette use, last month snus use, 
anxiety and depression levels) on the intent to use AAS at wave 3 were examined using 
hierarchical multiple regression analysis. The hierarchical regression analysis included three 
steps; with intent to use AAS scale at wave 2 in the first step, physical and verbal aggression 
at wave 2 added to model at the second step, and the last step including all the indicators. 
Preliminary analysis of assumptions (i.e., normality, linearity, multicollinearity, and 
homoscedasticity) of hierarchical multiple regression analysis was conducted. With residuals 
of the intent to use AAS variable not normally distributed, this variable was log-transformed 
to improve its statistical properties. Since living situation was a nominal variable with six 
categories (both parents, single parent, shuttling between parents, alone, 
household/dormitory, and other), it was dummy coded with ‘other’ as the reference category. 
RStudio version 1.1.463 (RStudio, Inc) was used to conduct the analysis. 
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3. Results  
3.1 Results of Study 1 
After the final round of screening 238 full-text records, 12 studies were included in 
the meta-analysis. Altogether, 562 healthy males (females: n = 0) participated in the included 
studies and their age ranged from 18 (Su et al., 1993) to 49 (Carré et al., 2017) with a grand 
mean of 25.83 (SD = 3.80). Publication year ranged from 1992 (Anderson, Bancroft, & Wu, 
1992) to 2017 (Carré et al., 2017; Cueva et al., 2017; Panagiotidis et al., 2017) with four 
studies conducted in the US (Pope et al., 2000; Su et al., 1993; Tricker et al., 1996; Yates et 
al., 1999), four in the UK (Anderson et al., 1992; Cueva et al., 2017; O’Connor et al., 2002, 
2004), and one study each in Germany (Panagiotidis et al., 2017), Ireland (Dreher et al., 
2016), Finland (Björkqvist et al., 1994), and Canada (Carré et al., 2017), respectively.  
Of the total of twelve studies included, one study was a single-blind RCT (Anderson 
et al., 1992) and the rest were double-blind RCTs. Half of the included studies were cross-
over studies (Anderson et al., 1992; Cueva et al., 2017; O’Connor et al., 2004; Pope et al., 
2000; Su et al., 1993; Yates et al., 1999) and the other half were between-subject studies 
(Björkqvist et al., 1994; Carré et al., 2017; Dreher et al., 2016; O’Connor et al., 2002; 
Panagiotidis et al., 2017; Tricker et al., 1996).  
The included studies varied in the type of AAS administered to the participants. Four 
studies administered testosterone enanthate (Anderson et al., 1992; Dreher et al., 2016; 
O’Connor et al., 2002; Tricker et al., 1996), two studies administered testosterone cypionate 
(Pope et al., 2000; Yates et al., 1999), two studies administered testosterone undecanoate 
(Björkqvist et al., 1994; O’Connor et al., 2004), three studies administered testosterone gel 
(Carré et al., 2017; Cueva et al., 2017; Panagiotidis et al., 2017), and one study administered 
methyltestosterone (Su et al., 1993). AAS doses ranged from a one-time application of 50 
mg of testosterone gel (Panagiotidis et al., 2017) to the injection of 1000 mg of testosterone 
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undecanoate (O’Connor et al., 2004), and the injection of a total of 7000 mg of testosterone 
enanthate over a 14-week period (Yates et al., 1999).  
Moreover, the included studies varied in the measures used to assess aggression. 
Three studies (O’Connor et al., 2002, 2004; Pope et al., 2000) utilized the Buss-Perry 
Aggression Questionnaire (Buss & Perry, 1992), three studies (O’Connor et al., 2002, 2004; 
Yates et al., 1999) utilized the Buss-Durkee Hostility Inventory (Buss & Durkee, 1957), two 
studies (Carré et al., 2017; Pope et al., 2000) utilized the Point Subtraction Aggression 
Paradigm (Cherek, 1992), and three studies (Dreher et al., 2016; O’Connor et al., 2002, 
2004) utilized the Profile of Mood States (McNair et al., 1992). In addition to the Profile of 
Mood States, O’Connor et al. (2002, 2004) utilized the Aggression Provocation 
Questionnaire (O’Connor et al., 2001). Moreover, one study (Björkqvist et al., 1994) utilized 
the Self-Estimated Mood Checklist (Lindman, 1985), one study (Panagiotidis et al., 2017) 
utilized the Technical Provocation Paradigm (Panagiotidis et al., 2017) and emotional self-
ratings (Schneider et al., 1994). Furthermore, two studies (Cueva et al., 2017; Su et al., 1993) 
utilized visual analogue scales (Cline et al., 1992; Norris, 1971), one study (Tricker et al., 
1996) utilized the Multidimensional Anger Inventory (Siegel, 1986), and one study 
(Anderson et al., 1992) used daily ratings of irritability, readiness to fight, and being easily 
angered. 
There was no significant effect of AAS administration and aggression in ten of the 
included studies (Anderson et al., 1992; Carré et al., 2017; Cueva et al., 2017; Dreher et al., 
2016; O’Connor et al., 2002, 2004; Panagiotidis et al., 2017; Pope et al., 2000; Tricker et al., 
1996; Yates et al., 1999). Further, one study (Su et al., 1993) reported a significant positive 
effect of AAS administration on aggression, whereas one study (Björkqvist et al., 1994) 
reported a significant negative effect of AAS administration on aggression. 
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The two reviewers who assessed the risk of bias for all the included studies disagreed 
once on the random sequence generation dimension of the selection bias which led to a 
Cohen’s kappa of .58 (Cohen, 1988). All the included studies were assessed as having a high 
risk of selection bias on the random sequence generation dimension and unclear risk of 
selection bias on the allocation concealment dimension. One single-blinded study (Anderson 
et al., 1992) was assessed to have a high risk of performance and detection bias whereas the 
rest of included studies were assessed to have unclear risk of performance and detection bias. 
In addition, all studies were evaluated as having low risk of attrition bias as the outcome data 
was reported. Moreover, except for one study (Björkqvist et al., 1994) that did not report 
means and standard deviations of measured aggression, all studies were assessed to have low 
reporting bias.  
Under a random-effects model, after eliminating an outlier which did not overlap 
with the 95% confidence interval of the overall pooled effect size (Björkqvist et al., 1994), a 
small significant and positive effect of AAS administration on self-reported aggression was 
observed (g = 0.171, 95% CI: 0.029–0.312, k = 11, p = .018; I2 = 0.000, Q = 8.891, p = 
.542). Under a random-effects model, the effect of administering AAS over longer periods (3 
days to 14 weeks) on self-reported aggression was not significant (g = 0.100, 95% CI: -
0.079–0.278, p = .273; I2 = 5.286, Q = 6.335, p = .321).  
Under a fixed-effect model, the effect of acute administration of AAS on self-
reported aggression was significant (g = 0.291, 95% CI: 0.014–0.524, p = .014, Q = .867, p 
= .833). Under a fixed-effect model, the effect of administering higher doses of AAS (over 
500 mg) on self-reported aggression was not significant (g = 0.191; 95% CI: -0.007–0.388, p 
= .059, Q = 1.399, p = .844). Similarly, results from the fixed-effect meta-regression 
analysis on the effect of AAS dose on self-reported aggression was not significant [B = 
0.000, SE = 0.000 (95% CI: -0.000–0.000), p = .096]. Furthermore, the overall fixed-effect 
 
55 
of AAS administration on observer-reported aggression was not significant (g = 0.157, 95% 
CI: -0.026–0.581, p = .469, Q = .249, p = .833) 
3.2 Results of Study 2 
Stanozolol (Winstrol, n = 136)), Testosterone (n = 114), oxandrolone (n = 73), 
Dianabol (methandrostenolone, (n = 71)), and Anadrol (oxymetholone (n = 62)) were the 
most frequently used type of AAS among both sexes.  
A five-class solution was the best model fit for the data (BIC = 4326.81, L2 = 
2220.11, p = 0.000, ACE = .02, entropy R2 = .94). MLCA was conducted to examine 
whether the same profiles of direct and indirect aggression and psychological distress can be 
applied to both sexes. Results of the MLCA indicated that the homogenous model was the 
best model and that patterns of direct and indirect aggression and psychological distress are 
not dependent on the sex of AAS users.  
For the five-class solution, Class 1 comprised members with the highest levels of 
direct and indirect aggression and moderate levels of psychological distress (high aggression 
moderate distress users: HAMoD; 7.63%). Class 2 members were characterized by moderate 
levels of direct and indirect aggression and psychological distress (moderate aggression 
distress users: MoAD; 18.64%). Class 3 consisted of users with moderate levels of direct 
aggression, mild levels of indirect aggression, and moderate levels of psychological distress 
(moderate direct aggression-mild indirect aggression moderate distress users: ModA-MiiA 
MoD; 22.95%). Class 4 comprised users with mild levels of direct aggression and moderate 
levels of indirect aggression as well as psychological distress (mild direct aggression-
moderate indirect aggression-distress users: MidA-MoiAD; 11.71%). Finally, Class 5 
comprised users with lowest levels of direct and indirect aggression and mild psychological 
distress (low aggression mild distress users: LAMiD; 39.06%).  
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Additionally, sex was significantly related to class membership (Wald = 31.04, p < 
.001). In particular, members of the HAMoD subgroup had a higher likelihood of being male 
(z = - 5.02, p < .001). In contrast, members of the LAMiD subgroup were more likely (z = 
3.51, p < .001) to be female.   
3.3 Results of Study 3 
The prevalence of AAS use among participants increased from 1 person at wave 2 to 
4 persons at wave 3. Intent to use AAS did not change from 18 to 19 years old. From wave 2 
to wave 3, physical aggression and verbal aggression decreased significantly in both sexes 
(males: wave 2: M = 6.6, SD = 3.1, wave 3: M = 5.9, SD = 2.9; t = 4.40, p ˂ .01; and 
females: wave 2: M = 6.1, SD = 3.0, wave 3: M = 5.5, SD = 2.4; t = 8.15, p ˂ .01). 
Correlation coefficients among the study variables at wave 2 and wave 3 indicated that intent 
to use AAS at Wave 2 was negatively correlated to GPA (r = -.07, p ˂ .05), alcohol misuse 
(r = -.06, p ˂ .01), past month cigarette use (r = -.13, p ˂ .01), and snus use (r = -.10, p ˂ 
.01).  
Intent to use AAS at wave 2 was positively associated with shuttling between parents 
(living situation, r = .06, p ˂ .05), anxiety (r = .09), depression (r = .11, p ˂ .01), and 
physical (r = .16, p ˂ .01) and verbal aggression (r = .10, p ˂ .01). Intent to use AAS at 
Wave 3 was positively correlated with last year AAS use (r = .22, p ˂ .01), anxiety (r = .06, 
p ˂ .05), depression (r = .12, p ˂ .01) and verbal (r = .12, p ˂ .01) and physical aggression 
(r = .18, p ˂ .01) but negatively correlated with past month cigarette use (r = -.10, p ˂ .01). 
Results from the first step of the hierarchical linear regression of predictors of intent 
to use AAS at wave 3 indicated that AAS use intent at wave 2 significantly accounted for 
8.2% of the variance in AAS use intent at wave 3 (F (1,1268) = 114.8, p ˂ .01). The second 
step explained 8.4% of the variance in intent to use AAS at the wave 3 (F (3, 1266) = 40.05, 
p ˂ .01). Here, physical aggression and verbal aggression at wave 2 were not associated with 
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intent to use AAS at wave 3. The third step included all the independent variables and 
significantly explained 15% of the variance of the AAS use intent at wave 3 (F (16, 957) = 
13.36, p ˂ .01) with being male (sex: β = -.066, p ˂ .01), living alone (β = .068, p ˂ .05), and 




The main aim of this thesis was to contribute to the existing evidence on the 
relationship between AAS use and aggression by: 1) systematically reviewing and 
synthesizing effects from RCTs on the association between AAS use and aggression, 2) 
exploring the patterns of aggression and psychological distress among male and female AAS 
users, and 3) examining the relationship between AAS use intent and aggression and 
exploring risk factors of AAS use intent across time. To attain these aims, three studies were 
conducted. The following discussion consists of findings from the aforementioned studies as 
well as implications for practice and future research, strengths, and limitations of the thesis.  
4.1 Main findings  
Based on the notion that RCTs and meta-analyses are methodologically superior to 
cross-sectional and longitudinal studies (Murad et al., 2016), in Study 1, a meta-analysis of 
RCTs examining the effect of AAS use on self-reported as well as observer-reported 
aggression was conducted. Under a random-effects model, after eliminating an outlier from 
the included studies, a significant positive effect of AAS administration on self-reported 
aggression was observed. This finding is in line with the finding from a recent meta-analysis 
(Geniole et al., 2020) suggesting that AAS administration has a marginally significant and 
positive correlation with aggressive behavior. Further, when restricting the analysis to 
studies in which acute (one dosage) AAS administration effects on aggression were 
examined, results were also significant. The meta-analysis by Geniole et al. (2020) attests to 
the finding that acute testosterone increase is positively associated with aggressive behavior.  
The positive effect of testosterone administration on aggression in RCTs can be 
explained in light of the dual-hormone hypothesis as well as the challenge hypothesis. Some 
of the included RCTs in the meta-analysis used behavioral measures of aggression and 
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assessed aggression after provoking the participants in a competitive context (Carré et al., 
2017; Dreher et al., 2016; Panagiotidis et al., 2017). Both the dual-hormone hypothesis and 
the challenge hypothesis emphasize the role of a competitive context for increased 
aggression (Mehta et al., 2015; Zilioli & Bird, 2017). In particular, the dual-hormone 
hypothesis suggests that in a competitive context, humans evolutionarily have lower levels 
of cortisol and higher levels of testosterone in order to execute aggressive and dominant 
behavior in favor of survival. The positive effect of acute AAS administration on self-
reported aggression can also be explained in light of the challenge hypothesis (Archer, 
2006). According to the challenge hypothesis, the relationship between testosterone levels 
and aggression depends on the social context. Testosterone levels tend to be higher in social 
contexts characterized by competition and aggression (Archer, 2006; Zilioli & Bird, 2017). 
In terms of the challenge hypothesis, it has been suggested that increased testosterone is 
associated with increased ongoing and/or future aggression (Geniole et al., 2020; Zilioli & 
Bird, 2017).  
However, no significant effects of long-term and high-dose AAS administration on 
self-reported aggression was observed. Further, there was no significant relationship between 
AAS administration and observer-reported aggression. In addition, results from the meta-
regression on the relationship between AAS administration and aggression using dose as the 
moderator was also insignificant. An important explanation for the above findings is that 
ecological settings are different from laboratory settings on various factors such as dosage, 
AAS types, and duration of use. AAS use is often part of a polydrug abuse pattern with AAS 
dosages ranging from 125 to 7,000 (mean = 1,278) mg per week over an average period of 
9.1 years (Bjørnebekk et al., 2017; Salinas et al., 2019). Moreover, in another study, it was 
shown that when adjusting for polysubstance use, the association between AAS use and 
aggressiveness diminished (Lundholm, 2013).  
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The notion that AAS use is predominantly a male practice (Sagoe et al., 2014a; 
Sagoe & Pallesen, 2018) was also observed in samples from RCTs included in Study 1. All 
participants in the RCTs on the relationship between AAS use and aggression were healthy 
males. It is known that female AAS users are generally understudied in terms of the 
psychological side effects of AAS use (Abrahin et al., 2017; Börjesson et al., 2016; Grogan e 
al., 2006; Havnes et al., 2020). Hence, in Study 2, the majority of the sample were female 
AAS users. More importantly, due to the paucity of knowledge about AAS users in non-
Western countries, particularly female AAS users, the data for Study 2 were collected from 
Iran.  
The first class identified in Study 2 comprised mostly male AAS users and it was the 
smallest subgroup with highest levels of direct aggression (i.e., physical and verbal 
aggression) and indirect aggression (i.e., anger and hostility) and moderate levels of 
psychological distress. The second subgroup also consisted of more males and users in this 
subgroup had moderate levels of direct aggression, indirect aggression, and psychological 
distress. These two subgroups corroborate previous findings from clinical observations, case 
reports and anecdotes that indicate a positive relationship between AAS use and aggression 
(Choi & Pope, 1994; Thiblin et al., 1997). As the aggression and psychological distress 
scores started to decrease, the proportion of females in the latent classes started to grow. The 
third subgroup consisted of users reporting moderate levels of direct aggression, mild levels 
of indirect aggression, and moderate levels of psychological distress. Further, the fourth 
subgroup consisted of mild levels of direct aggression and moderate levels of indirect 
aggression as well as psychological distress. Finally, the fifth subgroup which was the 
largest subgroup comprised mostly female AAS users, and was characterized by the lowest 
levels of direct and indirect aggression and psychological distress. Results from Study 2 
corroborate result from other studies in which majority of AAS users experienced aggressive 
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cognitions and affects (e.g., hostility, irritability, anger) instead of involvement in direct acts 
of aggression (Panagiotidis et al., 2017; Pope et al., 2000).  
Results of measurement invariance assessment indicates that the identified subgroups 
of aggression and psychological distress apply to both male and female AAS users. 
However, the proportion of male AAS users in the highly aggressive and psychological 
distress subgroups are significantly higher than female users. Hence, it can be inferred that 
AAS users who experience high aggression and psychological distress comprise of a higher 
proportion of males compared to females. This finding may be attributed to the fact that 
compared to females, males initiate AAS use at a younger age, use higher weekly doses, a 
higher number of AAS per cycle and over their lifetime, and practice more stacking, 
polypharmacy and pyramiding (Ip et al., 2010). Altogether, discrepancies in the patterns of 
aggression and psychological distress among AAS users in Study 2 are in line with previous 
studies indicating that not all AAS users experience high levels of aggression and 
psychological distress (Trenton & Currier, 2005), and that the effect of AAS administration 
on aggressive behaviors are stronger in males in comparison to females (Geniole et al., 
2020).  
Life history theory (LHT; Del Giudice, 2018) provides explanations for the above 
finding from Study 2. According to LHT, maladaptive aggression can be promoted by 
growing up in an unpredictable and harsh environment leading to a fast life history strategy 
(Del Giudice, 2018). It is plausible that AAS users in the more aggressive and 
psychologically distressed classes exhibit a fast life history strategy characterized by a “You 
Only Live Once” (YOLO; Christiansen et al., 2017; Zahnow et al., 2018) perspective. 
According to LHT, persons with a slow life history strategy are less likely to engage in risky 
behaviors and aggression since these behaviors may help immediate survival but do not 
optimize lifelong survival (Mittal & Griskevicius, 2014). Further, LHT posits that females 
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are evolutionary wired to inhibit maladaptive emotional and behavioral responses in order to 
optimize reproduction and childbearing likelihood (Bjorklund & Kipp, 1996).  
In line with the prevalence estimates from earlier Norwegian studies (Wichstrøm, 
2006; Wichstrøm & Pedersen, 2001), results from Study 3 showed that the prevalence of 
AAS use increased from 1 person at 18 years old to 4 persons at 19 years in Norway. These 
results could be attributed to evidence that only about 13% of AAS users are below 18 years 
old (Pope et al., 2014b) and most persons initiate use of AAS after age 18 (Sagoe et al., 
2014b). Moreover, Study 3 evidenced a temporal stability in AAS use intent from age 18 to 
19. Importantly, it was observed in Study 3 that physical and verbal aggression decreased in 
both sexes from late adolescence to early adulthood. This finding is consistent with results 
from previous studies which did not observe any increase in aggression level among 
adolescents longitudinally from age 15 to 17 (Olweus et al., 1988). It can also be supported 
by the maturation of brain areas in charge of inhibiting responses (e.g., aggressiveness) such 
as the frontal lobe during adolescence (Leon-Carrion et al., 2004). The finding of decreased 
physical and verbal aggression from age 18 to 19 can be explained by decreased endogenous 
testosterone level during this period (Steinberg, 2008) in support of the challenge and 
(Wingfield et al., 1990) dual-hormone (Mehta & Josephs, 2010) hypotheses. Additionally, 
the lack of a longitudinal relationship between physical or verbal aggression and AAS use 
intent from age 18 to 19 in Study 3 indicates that the positive relationship between AAS use 
intent and aggression at age 18 found using a cross-sectional design (Sagoe et al., 2016a) is 
not applicable longitudinally from age 18 to 19.  
In corroboration of previous studies suggesting that living alone is a risk factor for 
problem behaviors such as substance use and aggression among adolescents (Makanjuola et 
al., 2007), results from Study 3 indicated that living alone at age 18 is related to higher AAS 
use intent at age 19. In the context of problem behavior theory (Jessor & Jessor, 1977), the 
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finding that living alone is a risk factor for AAS use intent in Study 3 is understandable since 
adolescents living alone may have less parental supervision and higher exposure to problem 
behaviors such as AAS use and aggression (Fellmeth et al., 2018; Gestsdottir et al., 2020). 
Being male was another risk factor for AAS use intent at age 19 consistent with the 
traditional notion that AAS use is predominantly a male practice (Sagoe et al., 2014a; Sagoe 
& Pallesen, 2018). Overall, results from Study 3 are in line with previous studies suggesting 
that environmental risks, aggression, impulsiveness, and social problems during early 
adolescence are related to intent to and actual substance use in late adolescence (Ernst et al., 
2006; Harvey, 2020).  
4.2 Implications for practice and future research  
Findings from the studies included in this thesis have implications for AAS-related 
prevention, harm reduction and treatment as well as future research. One of the effective 
preventive approaches to AAS use is providing balanced information about its health 
consequences (Petróczi et al., 2014; Sagoe et al., 2016b). Including information on the 
behavioral consequences of AAS use, in particular emphasizing that AAS use increases 
aggression and the likelihood of engaging in violent crime (Christoffersen et al., 2019; 
Ganson & Cadet, 2019; Hauger et al., 2021), is important for effective information-based 
preventive approaches. Relatedly, preventive interventions addressing the factors identified 
in Study 3 as associated with the maintenance of high AAS use intent in the transition from 
adolescence and early adulthood (i.e., being male, living alone, and past or current use of 
AAS), may be effective in reducing AAS use intent and initiation. Moreover, evidence of an 
acute increase in aggression following AAS administration should be considered in harm 
reduction and treatment interventions. Here, mindfulness-based interventions may be 
effective in helping AAS users be more mindful of the increased tendency for aggression 
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especially when “on cycle” and facilitate AAS abstinence and cessation (Gardner & Moore, 
2012; Steyn et al., 2016).  
A systematic review on negative health consequences-based interventions suggests 
that the impact of such interventions highly depends on how the target group consider the 
intervention to be relevant to their group (Petróczi et al., 2014). Utilizing results from Study 
2, it is suggested that AAS-using females should be considered as an important group in 
policy making particularly in relation to the tendency for aggression. Additionally, findings 
on the heterogeneity denote the need for tailored interventions considering AAS users’ 
different profiles of aggression and psychological distress.  
The findings also have implications for future research. RCTs on the effect of AAS 
administration on aggression have several limitations including low doses, lack of 
personality and polypharmacy controls, small sample sizes, risk of bias, short study duration, 
and the inclusion of only healthy males. Premorbid functioning may also predispose some 
persons to the aggression-instigating effects of AAS (Piacentino et al., 2015; Pope & Katz, 
1990). Future RCTs considering these factors are also suggested to design experiments that 
are closer to ecologically valid settings so that they can contribute better to the evidence base 
on how AAS administration affects aggression in humans. It is also recommended that self-
report measures of aggression are systematically supplemented with other measures, which 
may have higher ecological validity, such as observer reports as well as more advanced 
methods such as virtual reality (Lobbestael, 2015).   
Also, considering the emphasis on the importance of personality traits in doping in 
general (Nicholls et al., 2017) and as a moderator of the relationship between AAS use and 
aggression in particular (Carré & Archer, 2018; Hauger et al., 2021; Pope et al., 2000), it 
would be of interest to examine the personality traits of the identified subgroups of AAS-
related aggression and psychological distress. Research on this topic could also benefit from 
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longitudinal designs in highlighting potential transitions between the identified subgroups of 
AAS-related aggression and psychological distress. In addition, i t could be of interest to 
replicate the identified subgroups and investigate the AAS types associated with members of 
each subgroup. Finally, further studies especially of longitudinal design should be conducted 
to shed light on the link between aggression and AAS use and intent. Larger sample sizes 
and innovative means of attrition prevention are recommended. Finally, in order to further 
elucidate the present findings, conducting similar research using different methods, samples 
particularly including females, factors, and in other cultural as well as geographic contexts is 
recommended.  
4.3 Strengths and limitations 
This thesis is methodically diverse comprising meta-analytic, cross-sectional, and 
longitudinal designs. Study 1 represents the first comprehensive systematic review and meta-
analysis on RCTs of the relationship between AAS administration and aggression. Study 2 is 
the first to identify typologies of aggression and psychological distress among male and 
female AAS users. Additionally, the use of multilevel latent class analysis (MLCA) to 
identify the subgroups is a strength as MLCA is superior to traditional categorization of 
subgroups using cut-off points (Berzofsky et al., 2008). Also, given the dearth of AAS 
research in nonwestern countries and particularly among females (Sagoe et al., 2014a; Sagoe 
& Pallesen, 2018), the inclusion of a large proportion of female AAS users from Iran in 
Study 2 is a strength. Moreover, Study 3 is the first to investigate the longitudinal 
associations between AAS use intent and aggression. Standardized and validated measures 
were used to examine this relationship in a nationally representative sample in the critical 
transition from late adolescence to early adulthood. Another strength of Study 3 is that the 
sample was randomly selected from the Norwegian Population Registry and the response 
rate was also relatively high. 
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Limitations of the studies also need to be pointed out. One major limitation pertains 
to the assessment of aggression. Most of these were based on self-report. However, a major 
limitation of such measures is that they often do not correspond well with actual behavior 
(Lobbestael, 2015), which may be due to social desirability bias (Vigil-Colet et al., 2012). 
Another limitation is that such measures seldom make a distinction between reactive and 
proactive aggression. This may be problematic given that testosterone exerts a direct causal 
influence on provoked aggressive behavior but correlates lower and only indirectly with 
unprovoked aggressive behavior (Olweus et al., 1988). 
The experimental settings in Study 1 had important gaps compared to ecological 
settings in which AAS use happens. As noted previously, these gaps include very low 
dosages, absence of polypharmacy control, small sample sizes, lack of gender diversity, 
including only healthy subjects, risk of bias, variation in aggression measures, and short 
duration of AAS exposure which may have diminished the robustness of the relationship 
between AAS use and aggression. It is therefore plausible that the identified positive effect 
of AAS administration on aggression may be exacerbated in ecological settings where AAS 
are obtained from ‘underground laboratories’ and sometimes contaminated with other toxic 
chemicals (Turnock, 2020; van de Ven et al., 2020) and are administered in 
supraphysiological doses for longer durations (Bjørnebekk et al., 2017; Salinas et al., 2019) 
concurrently with other substances (Dodge & Hoagland, 2011; Sagoe et al., 2015a). Another 
limitation of Study 1 is that there was substantial heterogeneity in the measurement of 
aggression (e.g., self-reports, observer reports, and behavioral) across the included RCTs.  
Additionally, considering the elevated psychological distress as a major symptom of 
AAS withdrawal (Harvey, 2020; Malone & Dimeff, 1992; Perry et al., 1990; Su et al., 1993), 
whether participants in Study 2 were “on cycle” or “off cycle” might have affected the 
subgroups of aggression and psychological distress identified. Altogether, the three studies 
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included in this thesis were quantitative, and qualitative explorations may throw further light 
on AAS use and aggression. Also, Studies 2 and 3 were cross-sectional and longitudinal 
respectively and causality can thus not be inferred from such designs. Additionally, in 
longitudinal studies, attrition is always a threat to external and internal validity of study 
results since it may result in underrepresentation of relevant subgroups (Barry, 2005). 
Further, the use of self-reports in Studies 2 and 3 is noteworthy as self-reports may be 
affected by social desirability bias and inaccurate responses (Hickman et al., 2002; Kanayma 
et al., 2007; Sagoe & Pallesen, 2018). In both Study 2 and Study 3, more females responded 
than men. This can be attributed to the notion that, overall, females respond to surveys more 
often than men do (Sax et al., 2003). In terms of power analysis, it should be noted that 
Study 1 is a meta-analysis. It is well known that meta-analyses increase statistical power for 
fixed effect models, and sometimes also for random effects models (Cohn & Bcker, 2003). 
Still, a formal a priori power analysis (Boresnstein et al., 2014) was not conducted for Study 
1. Although power analysis was not conducted for Study 2, the sample size seems adequate 
in terms of what is recommended for such analyses (Park & Yu, 2018). Study 3 is based on 
data from a larger research project focusing mainly on gambling among adolescents. A 
power calculation for this project showed that the sample size is sufficient to detect small 
effects in hierarchical multiple regression analyses (Faul et al., 2007). Furthermore, although 
most of the included measures in Studies 2 and 3 showed acceptable reliability, Cronbach’s 
alpha for the anger subscale of BPAQ-SF was .69 in Study 2 and around .67 for the verbal 




In the current thesis, three studies on the relationship between AAS and aggression 
are presented. Results of Study 1, based on a meta-analysis of RCTs, indicate a positive 
effect, although small, of AAS administration on aggression as well as a positive effect of 
acute AAS administration on aggression. In Study 2, using MLCA, male and female AAS 
users were classified into five subgroups according to their aggression and psychological 
distress levels. This underlines the sex homogeneity of AAS users’ aggression and 
psychological distress, although the proportion of male AAS users in the highly aggressive 
and psychological distress subgroups are significantly higher than female users. Results of 
Study 3 indicate that there is no longitudinal relationship between AAS use intent and 
physical and verbal aggression. Finally, in a longitudinal context, many other factors are 
influential in the maintenance of the relationship between AAS use intent and aggression. 
The three studies presented in this thesis have implications for AAS-related preventive, harm 
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Abstract
Rationale Aggression and irritability are notable psychiatric side effects of anabolic-androgenic steroid (AAS) use. However, no
previous study has systematically reviewed and quantitatively synthesized effects reported by experimental studies on this topic.
Objective We conducted a systematic review andmeta-analysis of randomized controlled trials (RCTs) investigating the effect of
AAS administration on self-reported and observer-reported aggression.
Methods Twelve RCTs comprising a total of 562 healthy males were identified through systematic searches of MEDLINE,
PsycInfo, ISI Web of Science, ProQuest, Google Scholar, and the Cochrane Library.
Results After excluding one outlier, AAS administration was associated with an increase in self-reported aggression under a
random-effects model, albeit small (Hedges’ g = 0.171, 95% CI: 0.029–0.312, k = 11, p = .018), and when restricting the analysis
to the effect of acute AAS administration on self-reported aggression under a fixed-effect model (g = 0.291, 95% CI: 0.014–
0.524, p = .014). However, the above effects were neither replicated in the analysis of observer-reported aggression nor after
restricting the analysis to the effects of the administration of higher (over 500 mg) and long-term (3 days to 14 weeks) doses.
Conclusions The present meta-analysis provides evidence of an increase, although small, in self-reported aggression in healthy
males following AAS administration in RCTs. Ecologically rational RCTs are warranted to better explore the effect of AAS
administration on aggression in humans.
Keywords Anabolic-androgenic steroids . Aggression .Meta-analysis . Randomized controlled trial
Introduction
Anabolic-androgenic steroids (AAS) are a family of hormones
comprising the androgen hormone testosterone as well as its
synthetic derivatives (Kanayama and Pope 2018). Use of AAS
was historically associated with weightlifters and later with
professional bodybuilders and elite athletes in various sports.
Since the 1980s, use of AAS has gradually spread to
recreational athletes as well as the general population
(Pope and Kanayama 2012). Use of AAS normally com-
prises long-term administration of supraphysiological
doses often 10–100 times the natural production or thera-
peutic doses of androgens (Kanayama et al. 2013). A meta-
analysis on the global prevalence of AAS use indicated that
3.3% of the world’s population has used AAS at least once
with use being more frequent among males (6.4%) com-
pared to (1.6%) females (Sagoe et al. 2014b; Sagoe and
Pallesen 2018).
Despite benefits such as increased muscle growth, im-
proved body image, and enhanced sports performance
(Evans 2004; Sagoe et al. 2014a; Smit et al. 2020a), hu-
man case studies, surveys, and experimental studies sug-
gest that AAS induce a plethora of physical and psycho-
logical adverse side effects. Cardiovascular disorders, par-
ticularly cardiomyopathy, are major physical side effects
of AAS use (Baggish et al. 2017). Other somatic side
effects of AAS include hypertension, sleep abnormalities,
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immunological dysregulation, decreased libido in males,
and hirsutism and clitoromegaly in females (Bensoussan
and Anderson 2019; Ganesan et al. 2020). Notable psycho-
logical side effects comprise manic and depressive symp-
toms as well as psychotic symptoms (Brower 2009;
Kanayama et al. 2020). Human case studies, surveys, and
experimental studies further suggest that AAS induce a
plethora of symptoms such as irritability and unprovoked
aggression sometimes referred to as “roid rage” or “steroid
rage” (Nelson 1989; Pope and Katz 1987; Taylor 1987;
Tragger 1988). Experimental animal studies show consis-
tently that injections of AAS increase aggression (Clark and
Henderson 2003; Lumia et al. 1994). For human studies,
cross-sectional (Ganson and Cadet 2019; Pereira et al.
2019), case-control (Klötz et al. 2007; Lundholm et al.
2010; Thiblin et al. 2015), and longitudinal (Beaver et al.
2008) researches indicate a positive relationship between
AAS use and aggression. However, results from human
placebo-controlled randomized studies show an inconsis-
tent association between AAS administration and aggres-
sion comprising negative (Björkqvist et al. 1994), positive
(Panagiotidis et al. 2017; Wagels et al. 2018), and non-
significant findings (Tricker et al. 1996).
Most previous reviews on this topic are merely narrative
(Haug et al. 2004; Huo et al. 2016; Johnson et al. 2013).
Additionally, a recent review (Geniole et al. 2020) on this
topic lacks some studies (Anderson et al. 1992; Björkqvist
et al. 1994; Su et al. 1993; Tricker et al. 1996). Hence, a
comprehensive systematic review quantifying findings on
the topic is overdue in line with the merit of meta-analyses
in science and evidence-based medicine (Murad et al.
2016). Against this backdrop, we conducted a systematic
review and meta-analysis of randomized controlled trials
(RCTs) examining the effect of AAS administration on




Systematic literature searches were conducted in MEDLINE,
PsycInfo, ISI Web of Science, ProQuest, Google Scholar, and
Cochrane Library. There was no time constraint for the search.
Keywords for AASwere combined with keywords for aggres-
sion. An overview of the keywords and search strategy can be
found in Appendix A in the Supplementary information. The
latest systematic literature search was conducted on 31
December 2019 followed by additional ad hoc searches to
ensure comprehensiveness. The search and selection process
are presented in Fig. 1.
Inclusion criteria and data extraction
Included studies were as follows: (1) RCTs, (2) investi-
gating the effects of AAS administration on aggression in
healthy persons, (3) based on valid aggression measures,
and (4) published in English. The first author (RC) inde-
pendently conducted the search and selection of articles
based on the aforementioned criteria. Using a standard-
ized data extraction form, the first and last (RC and DS)
authors independently extracted the following data from
the identified studies: study authors, country, design (e.g.,
double-blind), sample type (e.g., healthy males), sample
size, age (range, M ± SD), study groups (e.g., placebo
group), AAS type, AAS dose, AAS administration mode
(e.g., injection), study duration, assessment type (e.g.,
self-report), aggression measure, results, and risk of bias
(see Table 1). Furthermore, the testosterone levels both at
baseline and post-administration for each study are shown
in Table 2. The two authors reached consensus in cases of
discrepant extractions through discussions, with the in-
volvement of the second author SP) when necessary. We
also contacted corresponding authors or, when unavail-
able, coauthors via email for missing information.
Statistical analysis
We first investigated the overall effect of AAS administration
on self-reported aggression using a random-effects model.
AAS users typically administer supraphysiologic doses of
AAS for 4 to 28 weeks (Kanayama et al. 2013; Copeland
et al. 2000). We therefore subsequently pooled studies in
which higher doses (over 500 mg) of AAS were administered
for the examination of the effect of high-dose AAS adminis-
tration on self-reported aggression (O’Connor et al. 2004;
Pope et al. 2000; Su et al. 1993; Tricker et al. 1996; Yates
et al. 1999). Furthermore, we pooled studies in which AAS
were administered over longer periods (i.e., 3 days to 14
weeks: Anderson et al. 1992; Cueva et al. 2017; O’Connor
et al. 2002; O’Connor et al. 2004; Pope et al. 2000; Su et al.
1993; Yates et al. 1999) as well as studies investigating acute
AAS effects (Carré et al. 2017; Dreher et al. 2016;
Panagiotidis et al. 2017; Tricker et al. 1996). Due to the low
number of studies administering higher doses (k = 5) or in-
vestigating acute AAS effects (k = 4), a fixed-effect model
was used for these analyses (Borenstein 2009). Moreover,
we conducted a meta-regression analysis to elucidate a po-
tential dose-response association, regressing AAS dose
(mg) on self-reported aggression. Finally, we investigated
the overall effect of AAS administration on observer-
reported aggression using a fixed-effect model due to the
low number of studies (k = 3: O’Connor et al. 2004; Tricker
et al. 1996; Yates et al. 1999).
Psychopharmacology
Some studies used multiple aggression measures and re-
ported multiple aggression scores (O’Connor et al. 2002,
2004; Panagiotidis et al. 2017; Pope et al. 2000; Su et al.
1993). In these cases, we set the correlation between aggres-
sion measures to 0.60 (Diamond and Magaletta 2006;
O’Connor et al. 2001) to provide the best estimates of
between-study variance and corresponding confidence inter-
vals (Gleser and Olkin 2009; Marín-Martínez and Sánchez-
Meca 1999). For crossover studies (O’Connor et al. 2004;
Pope et al. 2000; Su et al. 1993; Yates et al. 1999), we used
an average correlation of 0.50 between aggression measures
over time to provide optimal effect size estimates (Krahé and
Möller 2010). Effects were estimated as Hedges’ g, where
0.20 is considered small, 0.50 moderate, and 0.80 as large
effect sizes, respectively (Hedges and Olkin 2014). For studies
including a passive control group (e.g., no intervention), a
placebo group, and a treatment group (Björkqvist et al.
1994), data from the placebo and treatment groups were used
to estimate meaningful relative-effect estimates (Karlsson and
Bergmark 2015; Magill and Longabaugh 2013). Effect sizes
were calculated by pooling post-intervention mean and stan-
dard deviations of aggression scores. When mean and stan-
dard deviation were not reported or unavailable in the original
paper, authors were approached by email (Björkqvist et al.
1994), and asked to provide statistical information (i.e., F
and p values) necessary to calculate effect sizes. For the as-
sessment of heterogeneity, we used the Q-statistic and the I2
index. The latter indicates the proportion of the observed var-
iance that reflects real differences in effect size. It is expressed
as a percentage (0–100) with 0% indicating no heterogeneity,











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































25% indicating low heterogeneity, 50% indicating moderate
heterogeneity, and 75% suggesting high heterogeneity
(Higgins et al. 2003) respectively. Additionally, we used
Duval and Tweedie’s (2000) trim and fill method, and
Orwin’s (1983) fail-safe N to assess publication bias. The trim
and fill method (Duval and Tweedie 2000) screens for missing
studies and adjusts the effect size by trimming the asymmetric
studies and filling a funnel plot symmetrically. Orwin’s
(1983) fail-safe N quantifies the number of studies required
to bring the observed effect size down to a chosen “trivial”
estimate (Hedges and Olkin 2014). In the current meta-analy-
sis, we set the “trivial” estimate to g of 0.05.
The quality of each included study was assessed using the
Cochrane risk of bias tool (Higgins et al. 2003). The protocol
for the meta-analysis was pre-registered in PROSPERO (CRD
42019117834). The literature search, coding of variables, and
reporting were conducted according to the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) procedure (Moher et al. 2009). The meta-analysis
and the meta-regression were performed using the
Comprehensive Meta-Analysis version 3.3.070 (Borenstein
et al. 2014).
Results
Literature screening and selection
From an initial pool of 30,407 hits, 18,988 records remained
after removal of duplicates (k = 3772) and gray literature (k =
7649) during initial identification and screening. Of this pool,
18,752 were removed after eligibility screening by title and
abstract leaving 238 records for further evaluation. After
screening the 238 full-text records, 12 studies were finally
included. Figure 1 presents the literature search and selection
process.
Description of included studies
Of the twelve included studies, publication year ranged from
1992 (Anderson et al. 1992) to 2017 (Carré et al. 2017; Cueva
et al. 2017; Panagiotidis et al. 2017). Four of the studies were
conducted in the USA (Pope et al. 2000; Su et al. 1993;
Tricker et al. 1996; Yates et al. 1999), four in the UK
(Anderson et al. 1992; Cueva et al. 2017; O’Connor et al.
2002, 2004), and one each in Germany (Panagiotidis et al.
2017), Finland (Björkqvist et al. 1994), Ireland (Dreher et al.
2016), and Canada (Carré et al. 2017). We received clarifica-
tion and data from some authors (Björkqvist et al. 1994; Carré
et al. 2017; Cueva et al. 2017; Dreher et al. 2016; O’Connor
et al. 2004). (See Table 1.)
All the included studies comprised placebo-controlled ran-


















































































































































































































































































































































































































































































































































































































































































(Anderson et al. 1992) and 11 were double-blinded.
Addi t ional ly, six studies were crossover s tudies
(Anderson et al. 1992; Cueva et al. 2017; O’Connor et al.
2004; Pope et al. 2000; Su et al. 1993; Yates et al. 1999)
whereas five were based on a between-subject design
(Björkqvist et al. 1994; Carré et al. 2017; Dreher et al.
2016; O’Connor et al. 2002; Panagiotidis et al. 2017;
Tricker et al. 1996). The studies included a total of 562
healthy male (females: n = 0) participants. Participants’
ages ranged from 18 (Su et al. 1993) to 49 (Carré et al.
2017) with a grand mean of 25.83 (SD = 3.80).
Testosterone enanthate was administered in four studies
(Anderson et al. 1992; Dreher et al. 2016; O’Connor et al.
2002; Tricker et al. 1996) and two studies administered tes-
tosterone cypionate (Pope et al. 2000; Yates et al. 1999). In
addition, two studies administered testosterone undecanoate
(Björkqvist et al. 1994; O’Connor et al. 2004), and three stud-
ies administered testosterone gel (Carré et al. 2017; Cueva
et al. 2017; Panagiotidis et al. 2017) whereas one study ad-
ministered methyltestosterone (Su et al. 1993). AAS doses
ranged from a one-time application of 50 mg of testosterone
gel (Panagiotidis et al. 2017) to a one-time injection of
1000 mg of testosterone undecanoate (O’Connor et al.
2004), and a cumulative injection of 7000 mg of testosterone
cypionate over a 14-week period (Yates et al. 1999). When
various doses of AAS were used in one study, we used results
from the highest dose for calculating the effect size.
Aggression was assessed by self-reports (Anderson et al.
1992; Björkqvist et al. 1994; Carré et al. 2017; Cueva et al.
2017; Dreher et al. 2016; O’Connor et al. 2002, 2004;
Panagiotidis et al. 2017; Pope et al. 2000; Su et al. 1993;
Tricker et al. 1996; Yates et al. 1999), observer-reports
(O’Connor et al. 2004; Tricker et al. 1996; Su et al. 1993;
Yates et al. 1999), and behavioral aggression measures
(Carré et al. 2017; Pope et al. 2000). The Buss-Perry
Aggression Questionnaire (Buss and Perry 1992) was used
in three studies (O’Connor et al. 2002, 2004; Pope et al.
2000), and three studies (O’Connor et al. 2002, 2004; Yates
et al. 1999) used the Buss-Durkee Hostility Inventory (Buss
and Durkee 1957), two studies (Carré et al. 2017; Pope et al.
2000) used the Point Subtraction Aggression Paradigm
(Cherek et al. 1996), and three studies (Dreher et al. 2016;
O’Connor et al. 2002, 2004) used the Profile of Mood States
(McNair et al. 1992) with two out of these three studies
(O’Connor et al. 2002, 2004) additionally using the
Aggression Provocation Questionnaire (O’Connor et al.
2001).
Additionally, the Self-Estimated Mood Checklist
(Lindman 1985) was used in one study (Björkqvist et al.
1994), and one study (Panagiotidis et al. 2017) used the
Technical Provocation Paradigm (Panagiotidis et al. 2017)
and emotional self-ratings (Schneider et al. 1994).
Moreover, two studies (Cueva et al. 2017; Su et al. 1993) used
visual analogue scales (Cline et al. 1992; Norris 1971), one
study (Tricker et al. 1996) used the Multi-Dimensional Anger
Inventory (Siegel 1986), and one study (Anderson et al. 1992)
used daily ratings of irritability, readiness to fight, and being
easily angered. 10 studies (Anderson et al. 1992; Carré et al.
2017; Cueva et al. 2017; Dreher et al. 2016; O’Connor et al.
2002, 2004; Panagiotidis et al. 2017; Pope et al. 2000; Tricker
et al. 1996; Yates et al. 1999) reported no significant effect of
AAS administration on aggression. In addition, one study (Su
et al. 1993) found a positive effect of AAS administration on
aggression (p < .05), whereas one study (Björkqvist et al.
1994) reported a negative effect of AAS administration on
aggression (p < .01).
Table 2 Mean baseline and post-
administration levels of placebo
and testosterone for each study
(nmol/L)





Anderson 1992 19.20 33.10 17.70 28.80
Björkqvist 1994 - - - -
Carré 2017 18.38 19.07 19.07 30.16
Cueva 2017 1.04 1.04 .69 10.05
Dreher 2016 20.46 20.44 21.06 66.08
O’Connor 2002 20.10 20.0 21.70 38.42
O’Connor 2004 20.30 20.30 20.70 37.50
Panagiotidis 2017 16.99 15.0 16.62 21.20
Pope 2000 16.30 18.40 17.40 76.00
Su 1993 - - - -
Tricker 1996 18.60 19.40 16.10 76.90
Yates 1999 20.82 19.08 20.82 73.73
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Risk of bias
The two authors disagreed once on the random sequence gen-
eration dimension for all the included studies yielding a
Cohen’s kappa of .58 (Cohen 1988). All studies were evalu-
ated as having a high selection bias as there was no description
of the randomization method or concealed allocation process.
In addition, all studies were evaluated as having high risks of
performance and detection bias as the effectiveness of
blinding was not tested. Moreover, all studies had a low risk
of attrition bias as there was sufficient reporting and handling
of attrition and exclusion. Furthermore, except for one study
that did not present means and standard deviations or inferen-
tial indices (Björkqvist et al. 1994), we evaluated all studies as
having low reporting bias. Figure 2 depicts the risk of bias of
the included studies.
Effect of AAS administration on self-reported
aggression
Of the twelve included studies, one study (Björkqvist et al.
1994) did not overlap with the 95% CI of the overall pooled
effect size. Exclusion of this outlier resulted in a mean and
significant random-effects size of g = 0.171 (95% CI:
0.029–0.312, k = 11, p = .018), and there was no significant
heterogeneity between the included studies (I2 = 0.000,Q =
8.891, p = .542). The effect sizes and associated 95% con-
fidence intervals are presented in Fig. 3.
The overall random-effects of AAS administration on self-
reported aggression, including the outlier (Björkqvist et al.
1994), was not significant (g = 0.081, 95% CI: −0.111–
0.273, p = .408). (See Supplementary Figure 1.) When
adjusting for publication bias using Duval and Tweedie’s trim
and fill method, the overall result (k = 12) turned out non-
significant (g = 0.170, 95% CI: 0.029–0.312, p = .890). (See
Supplementary Figure 2.) Results from Orwin’s fail-safe N
analysis indicated that 27 studies with an effect size of zero
would be needed to bring Hedges’ g below 0.05.
Effect of long-term AAS administration
on self-reported aggression
The random-effects of administering AAS over longer periods
(3 days to 14 weeks) on self-reported aggression under a
random-effects model was g = 0.100 (95% CI:−0.079–
0.278, p = .273). There was no significant heterogeneity
across studies in terms of effect sizes (I2 = 5.286, Q = 6.335,
p = .321). (See Fig. 4.)
Effect of acute AAS administration on self-reported
aggression
Under a fixed-effect model, the effect of acute administration
of AAS on self-reported aggression was g = 0.291 (95% CI:
0.014–0.524, p = .014, Q =.867, p = .833 ). (See Fig. 5.)
Effect of AAS dose on self-reported aggression
AAS dose (mg) was not associated with self-reported aggres-
sion in a random-effects meta-regression model (B = 0.000,
SE = 0.000 (95% CI: −0.000–0.000), p = .096).
Effect of high-dose AAS administration on self-
reported aggression
The mean effect of higher doses (over 500 mg) of AAS on
self-reported aggression under a fixed-effect model was non-
significant (g = 0.191; 95% CI: −0.007–0.388, p = .059, Q =
1.399, p = .844). (See Fig. 6.)Fig. 2 Estimated risk of bias of the included studies
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Effect of AAS administration on observer-reported
aggression
The overall fixed-effect of AAS administration on aggression
based on observer ratings resulted in an effect size of g = 0.157
(95% CI: −0.026–0.581, p = .469, Q = .249, p = .833). The
effect sizes and associated 95% confidence intervals for each
study are presented in Fig. 7.
Discussion
The present systematic review and meta-analysis of eleven
studies (Anderson et al. 1992; Carré et al. 2017; Cueva et al.
2017; Dreher et al. 2016; O’Connor et al. 2002, 2004;
Panagiotidis et al. 2017; Pope et al. 2000; Su et al. 1993;
Tricker et al. 1996; Yates et al. 1999), after excluding an
outlier (Björkqvist et al. 1994), indicates that AAS adminis-
tration is associated with an increase in self-reported aggres-
sion, albeit small, among healthy males in RCTs. This finding
is consistent with the results of a recent meta-analysis
(Geniole et al. 2020) indicating that testosterone administra-
tion has a small and positive correlation with aggression in
males. Relatedly, our finding that acute AAS administration
has a positive effect on self-reported aggression is consistent
with evidence that acute increases in testosterone have a pos-
itive correlation with aggression (Geniole et al. 2020).
The present study is the first comprehensive systematic
review and meta-analytic investigation of the effect of AAS
administration and aggression in healthy males in RCTs.
However, our results should be interpreted with caution.
Firstly, a meta-regression examining dosage as a moderator
of the identified effect of AAS on self-reported aggression
turned out not significant. Similarly, we did neither detect an
effect of AAS administration on observer-reported aggression
nor for the effects of long-term (3 days to 14 weeks) and high-
dose AAS administration on self-reported aggression. Also, as
noted previously, only healthy males were examined in the
included RCTs and the duration and doses used in the twelve
RCTs deviate from the prolonged use of high-dose cycles
consisting of the ingestion of supraphysiologic doses of dif-
ferent types of AAS per week over several months (Kanayama
Study name Statistics for each study Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error Variance limit limit Z-Value p-Value
Anderson 1992 -0.349 0.302 0.091 -0.940 0.242 -1.157 0.247
Carre 2017 0.393 0.188 0.035 0.025 0.762 2.094 0.036
Cueva 2017 -0.346 0.321 0.103 -0.975 0.282 -1.081 0.280
Dreher 2016 0.072 0.310 0.096 -0.537 0.680 0.231 0.817
O'Connor 2002 0.299 0.361 0.130 -0.408 1.006 0.829 0.407
O'Connor 2004 0.218 0.164 0.027 -0.104 0.540 1.327 0.185
Panagiotidis 2017 0.268 0.195 0.038 -0.114 0.650 1.375 0.169
Pope 2000 0.000 0.273 0.075 -0.535 0.535 0.000 1.000
Su 1993 0.299 0.184 0.034 -0.062 0.660 1.622 0.105
Tricker 1996 0.313 0.415 0.172 -0.500 1.126 0.755 0.450
Yates 1999 0.000 0.284 0.081 -0.556 0.556 0.000 1.000
0.171 0.072 0.005 0.029 0.312 2.365 0.018
-1.00 -0.50 0.00 0.50 1.00
Negative effect Positive effect
Overall
Fig. 3 The effect (random-effects model) of AAS administration on self-reported aggression
Study name Statistics for each study Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error Variance limit limit Z-Value p-Value
Anderson 1992 -0.349 0.302 0.091 -0.940 0.242 -1.157 0.247
Cueva 2017 -0.339 0.320 0.103 -0.967 0.289 -1.058 0.290
O'Connor 2002 0.299 0.361 0.130 -0.408 1.006 0.829 0.407
O'Connor 2004 0.218 0.164 0.027 -0.104 0.540 1.327 0.185
Pope 2000 0.000 0.273 0.075 -0.535 0.535 0.000 1.000
Su 1993 0.299 0.184 0.034 -0.062 0.660 1.622 0.105
Yates 1999 0.000 0.284 0.081 -0.556 0.556 0.000 1.000
0.094 0.095 0.009 -0.091 0.279 0.993 0.321
-1.00 -0.50 0.00 0.50 1.00
Negative effect Positive effect
Overall
Fig. 4 The effect (random-effects model) of administering AAS over longer periods on self-reported aggression
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et al. 2013) often reported by users in ecologically valid set-
tings. In one study, the reported weekly AAS dose ranged
from 125 to 7000 (mean = 1278) mg per week over an average
of 9.1 years (Bjørnebekk et al. 2017). In another recent study,
it was shown that an AAS cycle usually comprises the inges-
tion of five different AAS with an average dose of 901 mg per
week for a typical duration of 13 weeks (Smit et al. 2020b). In
the present meta-analysis, the highest dose administered was a
one-time injection of 1000 mg of testosterone undecanoate
(O’Connor et al. 2004) and a cumulative injection of
7000 mg of testosterone cypionate over a 14-week period
(Yates et al. 1999). Inferably, AAS doses and duration of
administration in the RCTs included in our meta-analysis are
far lower than the actual doses reported by AAS users
(Bjørnebekk et al. 2017; Kanayama et al. 2013).
Similarly, besides the administration of methyltestosterone
in one study (Su et al. 1993), fluoxymesterone, oxymetholone,
and trenbolone that are anecdotally associated with increased
aggression in humans (Barker 1987; Llewellyn 2011) were
not administered in the RCTs included in the present review.
Moreover, testosterone undecanoate administered in two stud-
ies (Björkqvist et al. 1994; O’Connor et al. 2004) is a depot
with a very gradual decay and long half-life leading to rela-
tively stable testosterone levels over a prolonged period of
time (Hirschhäuser et al. 1975). Hence, discrepancies in
AAS doses, type, duration of use, and half-life between the
AAS in the RCTs and naturalistic contexts should be noted
when interpreting our findings.
In addition, evidence from cross-sectional studies indicates
that polypharmacy and stacking (Sagoe et al. 2015; Salinas
et al. 2019) may account for increased aggression amongAAS
users (Lundholm et al. 2015). The absence of polypharmacy
in the RCTs included in our meta-analysis may also explain
the discrepancy between findings from RCTs and those re-
ported in more ecologically valid contexts. Other potential
confounding factors include small sample sizes and lack of a
priori power analyses, diversity in aggression measures, risk
of bias (selection, performance, and detection biases), diversi-
ty in route of administrating AAS (injecting, transdermally),
diversity in time gap between AAS administration, incom-
plete data reporting, and sampling of only males in included
RCTs.
Moreover, the inclusion of only healthy volunteers in
the RCTs may have precluded vulnerable subjects from
participating which may have led to the underestimation
of the effects of AAS administration on aggression.
Sampling is important with evidence that testosterone in-
creases aggression in men with certain personality profiles
especially among those with fewer cytosine-adenine-
guanine repeats in exon 1 of the androgen receptor gene
(Geniole et al. 2019). The importance of sampling is fur-
ther evidenced in that, apart from bodybuilders and com-
petitive athletes, a large portion of non-experimental re-
search linking AAS use with aggression has been con-
ducted among subgroups associated with aggression such
as drug users, offenders, and prisoners (Lundholm et al.
Study name Statistics for each study Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error Variance limit limit Z-Value p-Value
Carre 2017 0.393 0.188 0.035 0.025 0.762 2.094 0.036
Dreher 2016 0.060 0.310 0.096 -0.548 0.669 0.194 0.846
Panagiotidis 2017 0.268 0.195 0.038 -0.114 0.650 1.375 0.169
Tricker 1996 0.313 0.415 0.172 -0.500 1.126 0.755 0.450
0.291 0.119 0.014 0.059 0.524 2.453 0.014
-1.00 -0.50 0.00 0.50 1.00
Negative effect Positive effect
Overall
Fig. 5 The effect (fixed-effect model) of acute AAS administration on self-reported aggression
Study name Statistics for each study Dose Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error Variance limit limit Z-Value p-Value
O'Connor 2004 0.218 0.164 0.027 -0.104 0.540 1.327 0.185 1000
Pope 2000 0.000 0.273 0.075 -0.535 0.535 0.000 1.000 600
Su 1993 0.299 0.184 0.034 -0.062 0.660 1.622 0.105 240
Tricker 1996 0.313 0.415 0.172 -0.500 1.126 0.755 0.450 600
Yates 1999 0.000 0.284 0.081 -0.556 0.556 0.000 1.000 500
0.191 0.101 0.010 -0.007 0.388 1.887 0.059
-1.00 -0.50 0.00 0.50 1.00
Negative effect Positive effect
Overall
Fig. 6 The effect (fixed-effect model) of administering higher (over 500 mg) doses of AAS on self-reported aggression
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2010; Pope et al. 1996), as well as policemen, doormen,
and nightclub bouncers (Hoberman 2017; Midgley et al.
2001). Future researchers considering the aforementioned
factors may conduct more ecologically valid RCTs (e.g.,
by using dosages and duration of use similar to those by
real AAS users) to better elucidate the effect of AAS
administration on aggression in humans. Furthermore,
more studies should explore factors of AAS administra-
tion (e.g., type of AAS, duration of use, premorbid func-
tioning, and genetics) that might moderate the effects of
AAS on aggression.
Conclusions
The present systematic review and meta-analysis provide
evidence for an increase, although small, in self-reported
aggression in healthy males following AAS administration
in RCTs. Moreover, when restricting the analysis to the
effects of acute AAS administration on self-reported ag-
gression, we found a significant effect. We also identified
important limitations of the RCTs on issues such as non-
ecological doses, lack of personality and polypharmacy
controls, small sample sizes, risk of bias, short study dura-
tion, and the inclusion of only healthy males. While future
RCTs adjusting for the above factors may contribute better
to contemporary understanding of the effect of AAS admin-
istration on aggression in humans, the present study pro-
vides an important foundation for addressing this important
public health issue. As the appreciation of the heterogeneity
of AAS use matures, there is a need to identify the role that
AAS plays in aggression and violence and what may be
attributed to the set and setting of their use.
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The relationship between anabolic-androgenic steroid (AAS) use and aggression and 
psychological distress requires further elucidation. To our knowledge, no previous study has 
examined whether the patterns of aggression and psychological distress are the same in male 
and female AAS users by multigroup latent class analysis (MLCA). We therefore conducted a 
MLCA to identify discrete subgroups of aggression and psychological distress in AAS users, 
and used measurement invariance to examine whether the identified subgroups can be applied 
to both sexes. We also examined the relationship between sex and subgroup belongingness. 
The sample comprised 206 AAS users (females = 58.30%) aged 14 to 56 (mean = 26.86, SD = 
7.12 years). They completed questionnaires assessing demographics, AAS use, aggression, 
and psychological distress. Based on the MLCA, five subgroups were identified: high 
aggression moderate distress users (HAMoD: 07.63%), moderate aggression distress users 
(18.64%), moderate direct aggression-mild indirect aggression moderate distress users 
(22.95%), mild direct aggression-moderate indirect aggression-distress users (11.71%), and 
low aggression mild distress users (LAMiD: 39.06%). Although a homogenous five-class 
solution was the best model for both sexes, sex was significantly associated with the 
probability of subgroup membership. In particular, members of the HAMoD subgroup were 
more likely to be male whereas members of the LAMiD subgroup were more likely to be 
female. Our study provides novel empirical evidence of the idiosyncratic patterns of 
aggression and psychological distress among male and female AAS users.  








Anabolic-androgenic steroids (AAS) comprise testosterone and its synthetic derivatives. 
These drugs are used for treatment of insufficient testosterone production and cachexia 
associated with chronic diseases and advancing age (Ali and Garcia, 2014; Kicman, 2008). 
Due to its anabolic effects, AAS have typically been used by elite athletes and bodybuilders 
primarily to increase muscle mass and enhance strength. Further, AAS use has spread into the 
general population over the last four decades (Sagoe and Pallesen, 2018). The global lifetime 
prevalence of AAS use (Sagoe et al., 2014a) is estimated at 3.3% with a higher prevalence 
among males (6.4%) compared to females (1.6%).  
Users often ingest supra-physiological doses of AAS for years. Despite experiencing 
various aesthetic and performance benefits (Cheung and Grossmann, 2018; Sagoe et al., 
2014b), users also often report adverse physiological and psychological effects (Baggish et 
al., 2017; Bensoussan and Anderson, 2019; Christou et al., 2017; Cunningham et al., 2013; 
Hauger et al., 2019a, 2019b; Kaufman et al., 2019). The most well-known psychological 
adverse effect of AAS use among the general population is lack of impulse control, hostility, 
and high levels of aggressive and violent behavior, sometimes referred to as “roid rage” or 
“steroid rage” (Pope and Katz, 1987; Tragger, 1988). In line with this, numerous studies have 
indicated that AAS use is associated with aggression (Jenssen and Johannessen, 2015; Perry 
et al., 2005; Sagoe et al., 2016; Værøy, 2013) or increases in aggression (Panagiotidis et al., 
2017; Pope et al., 2000; Wagels et al., 2018), although experimental and longitudinal studies 
present contrasting evidence (Carré et al., 2017; Chegeni et al., 2019; O'Connor et al., 2002). 
From these inconsistent results, it is not clear whether all AAS users experience aggression 
and psychological distress upon use and whether there are unobserved patterns of aggression 
and psychological distress among AAS users. 
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Although characteristics of substance users as well as side-effects associated with 
different substances mainly are described at an aggregated level, identifying subgroups of 
such users and their behavioral outcomes can facilitate identification of at-risk individuals and 
groups most sensitive to the negative psychological consequences of AAS use, as well as the 
development of targeted interventions (Babor and Caetano, 2006; Lanza and Rhoades, 2013). 
In this regard, several studies have examined subgroups of substance users (Krauss et al., 
2017; Shin et al., 2010). These studies have mainly focused on alcohol and tobacco use 
(Evans-Polce et al., 2016; Morean et al., 2016). Patterns of risk and protective factors for 
behavioral outcomes of substance use have also been previously examined (Syvertsen et al., 
2010).  
Subgroups of AAS (Christiansen et al., 2017; Sagoe, 2014; Zahnow et al., 2018) and 
appearance- and performance-enhancing drug (APED) users (Hildebrandt et al., 2007) based 
on users’ approach to risk and effectiveness of AAS and use patterns have been identified in 
some previous studies. However, although aggression and psychological distress are major 
behavioral outcomes associated with AAS use (Cunningham et al., 2013; Havnes et al., 2019; 
Pagonis et al., 2006) as previously indicated, no previous study has examined subgroups of 
AAS users based on their aggression and psychological distress profile. Indeed, different 
APEDs are associated with different behavioral outcomes and it is important to examine these 
unique outcomes (Hildebrandt et al, 2007). A multigroup latent class analysis (MLCA; 
Lazarsfeld and Henry, 1968) is superior to traditional categorization of subgroups using cut-
off points (Berzofsky et al., 2008). Hence, we conducted a MLCA to assess physical 
aggression, verbal aggression, anger, and hostility and psychological distress patterns in male 
and female AAS users.  
Moreover, AAS use is predominantly a male practice and AAS use among females is 
an understudied area (Sagoe et al., 2014a; Sagoe and Pallesen, 2018). Relatedly, the few 
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studies that have examined the side effects of AAS use among females are based on small 
samples (Abrahin et al., 2017; Börjesson et al., 2016; Grogan et al., 2006; Havnes et al., 2020; 
Ip et al., 2010). In addition, males and females tend to use different doses and types of AAS 
and believe that the doses and the types they choose is best fitting to their sex (Abrahin et al., 
2017; Santos, 2014). More importantly, females are an important group in clinical practice 
and policy making on AAS use. Thus, information about patterns of aggression and 
psychological distress in AAS-using females is important. Accordingly, we included female 
AAS users in the current study to identify their patterns of aggression and psychological 
distress and to examine subgroups of female and male AAS users. We also investigated 
whether there are unobserved sex differences in the identified patterns.  
MATERIALS AND METHODS 
Participants  
Participants comprised 206 current AAS-using bodybuilders (females = 58.30%) with a 
history of at least six months’ regular AAS use prior to data collection. Age of participants 
ranged from 14 to 56 (M = 26.89, SD = 7.12) years. Other participant characteristics are 
presented in Table 1. 
Insert Table 1 about here 
Measures 
Demographics 
The questionnaire assessed demographic factors including age, sex, weight, height, 
educational level, marriage, and job status.  
Sports and Weight Training 
We assessed participants’ main involvement in sports and exercise as well as and total 
number of years of regular weight training. We also asked participants how many times per 




Current AAS use was assessed with the question “Do you currently use anabolic-androgenic 
steroids?” (yes/no). In verifying AAS use, participants specified the AAS they used (see Table 
1). For the assessment of AAS use duration, participants also indicated how long (years) they 
had been using AAS regularly.  
Aggression  
We used the Short-Form Buss-Perry Aggression Questionnaire (BPAQ-SF; Diamond and 
Magaletta, 2006; Samani, 2008) to assess aggression. Four items represent physical 
aggression (e.g., “I have trouble controlling my temper”), three items assess verbal aggression 
(e.g., “I often find myself disagreeing with people”), three items reflect hostility (e.g., “Other 
people always seem to get the breaks”), and two items measure anger (e.g., “Sometimes I fly 
off the handle for no good reason”). Items are answered on a 5-point Likert-type scale ranging 
from 1 (Very unlike me) to 5 (Very like me). In the present study, Cronbach’s  for physical 
aggression, verbal aggression, hostility, and anger were .73, .70, .77, and .69 respectively.   
Psychological Distress  
We assessed symptoms of psychological distress (anxiety and depression) using the Hospital 
Anxiety and Depression Scale (HADS; Montazeri et al., 2003; Zigmond and Snaith, 1983). 
HADS contains seven items reflecting anxiety symptoms (HADS-A; e.g., “I feel restless as I 
have to be on the move”) and seven items reflecting depressive symptoms (HADS-D; e.g., “I 
have lost interest in my appearance”) experienced over the last week. Items are scored on a 4-
point scale (0–3). We computed a composite score of anxiety and depression to indicate 
psychological distress in general, adhering to previous studies that have shown superior factor 
loadings of one general factor (Bjelland et al., 2002; Kjærgaard et al., 2014). Scores from 
HADS utilizing the general factor range from 0 to 56. In the present study, Cronbach’s  for 




Eligibility criteria for participation were being a current: (1) weightlifter and (2) regular AAS 
user for at least six months. Participants were recruited from training centers and sports 
supplement stores in Tehran, Iran. Data was collected via personal meetings at the training 
centers and supplement stores. All participants provided oral consent, participation was 
voluntary and anonymous, and participants could withdraw from participation. Upon 
participants’ consent, a trained research assistant handed paper questionnaires to participants 
for completion. Clarification about the questionnaire was provided when necessary. No 
incentive or compensation was provided for participation. Data was collected in June 2019. 
The study was conducted in accordance with the Declaration of Helsinki. Ethical approval 
was obtained from Alzahra University in Tehran, Iran. 
Statistical Analysis 
Descriptive statistics were used to determine characteristics of the sample. Characteristics of 
the sample was determined in terms of descriptive statistics as means and standard deviations 
for interval and ratio level variables and by percentages for nominal level variables. The 
major goal of the current study was to examine patterns of aggression and psychological 
distress in male and female AAS users, and to investigate whether the identified patterns can 
be applied to both sexes. First, we conducted a Latent Class Analysis (LCA; Bakk and 
Vermunt, 2016; Collins and Lanza, 2010) to examine discrete patterns of direct aggression 
(i.e., physical and verbal aggression), indirect aggression (i.e., anger and hostility), and 
psychological distress for the entire sample. In the context of present study, the 
aforementioned indicators were used to estimate latent classes of current AAS users. The 
Bayesian Information Criterion (BIC; Schwarz, 1978) is the most commonly used fit criteria 
to select the optimal number of latent classes (Collins and Lenza, 2010; Nylund et al., 2007). 
Models with lower values of information criteria have a better fit to the data (Kankaraš et al., 
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2010). A common approach is therefore to select the model with a number of latent classes 
which shows the lowest BIC (Hagenaars, 1990; McCutcheon, 1987). The likelihood-ratio chi-
square (L2) is a descriptive measure for assessing model fit and when L2 is significant it shows 
that the model does not fit the data. Entropy R2 and total proportion of adjacent classification 
error were used as indicators of the quality of the classification.  
Measurement invariance is required to determine whether the identified latent classes 
can be applied to both sexes (Kankaraš et al., 2010). Thus, after selecting a latent class model 
for the entire sample, we tested for measurement invariance across sex in order to make a 
valid comparison across subgroups of male and female AAS users (Clogg and Goodman, 
1985; McCutcheon, 1987). When comparing latent classes across groups, different levels of 
homogeneity (i.e., measurement invariance) can occur, each of which involves restricting 
specific sets of model parameters to be equivalent in all groups. There are three prototypical 
models that differ in the levels of measurement invariance (Clogg and Goodman, 1985). First 
is the homogeneous model which assumes that the latent classes have the same structure in 
each group. In this case effects of the group variable on the indicator variables are completely 
mediated by the latent classes. Hence, the homogeneous model imposes restrictions on the 
measurement model without deteriorating the fit with the data (Figure1a).  
Second is the partially homogeneous model where some of the model parameters are 
restricted to be equal in all groups. For example, when differences in answers of participants 
with different sexes are not associated with differences in a latent class, direct effects occur. 
Here, the goal is to examine whether the group variable has a direct effect on the indicator 
variables (Figure 1b). In addition, the heterogeneous model assumes that the latent classes 
have different structures in each group. In this unrestrictive model, the group variable has 
three sets of effects including effect on latent classes, direct effect on indicator variables, and 
interaction effects with latent classes on indicators. Hence, a heterogeneous model lacks any 
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comparability of results across groups as all measurement model parameters are group-
specific (Figure 1c).  
To test measurement invariance, we conducted homogeneous, partially homogeneous, 
and heterogeneous multigroup latent class analysis (MLCA) with sex as the grouping 
variable. Moreover, to relax the assumption of measurement invariance, we assumed that 
some, but not all, indicators are invariant across sex. We added the direct effect of the 
grouping variable on each indicator (in the partially homogeneous model). The goal of this 
step is to check the invariance of each indicator. See Figure 1 for details. A MLCA approach 
is flexible in the sense that not all latent classes need to be equivalent in order to validly 
compare results across groups.  
Insert Figure 1 about here 
Next, for comparing and choosing the best model for the data, we followed a model 
comparison procedure where difference in likelihood-ratio chi-square (L2) with a difference in 
degrees of freedom is used to determine which model is most appropriate. We calculated the 
difference in L2 and in degrees of freedom between consecutive nested models. The 
unrestricted heterogeneous model served as the baseline for this comparison. When moving 
from the homogenous model to the unrestricted heterogeneous model, if the difference in L2 
between two consecutive nested models (i.e., one model is obtained from a general model by 
imposing complex and decreasing homogeneity on the former) is significant, the model with 
more heterogeneity and less degrees of freedom fits the data best (Magidson and Vermunt, 
2002). Finally, class proportions for each group were examined. Here, participants were 
assigned to latent classes based on the likelihood of belonging to a class using the 
proportional assignment rule (Goodman, 2007; Magidson and Vermunt, 2002). We used the 
walt test to examine the relationship between sex and class membership. Descriptive analyses 
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were conducted using RStudio version 1.1.463 (RStudio, Inc). The MLCA was performed 
using advanced LatentGOLD 5.1 (Vermunt and Magidson, 2016). 
RESULTS 
Sample Description 
The average height and weight of female users were 165.11 (SD = 5.91) and 62.06 (SD = 
10.41) respectively. Male AAS users’ average weight and height were 180.46 (SD = 6.09) and 
84.64 (SD = 16.23) respectively. Female and male AAS users trained, on average, 4.37 (SD = 
3.38) and 6.19 (SD = 5.85) hours per week at the gym. The average AAS use duration was 
1.51 (SD = .66) years for males and 1.19 (SD = .43) years for females. Oxandrolone (Anavar) 
(males = 57, females = 55), testosterone (males = 66, females = 48), stanozolol (Winstrol) 
(males = 96, females = 40), Dianabol (methandrostenolone) (males = 96, females = 33), and 
Anadrol (oxymetholone) (males = 39, females = 23) were the most used types of AAS among 
both sexes. See Table 1 for other participant characteristics.  
Patterns of Latent Classes and Measurement Invariance 
Fit statistics for the latent classes are presented in Table 2. A 5-class solution was the best 
model as evident by the lowest BIC (4326.81). The squared log-likelihood (L2) was 2220.11 
(p = 0.000), the total proportion of adjacent classification errors was 0.02, and entropy R2 was 
.94. 
Insert Table 2 about here 
As the next step, considering the 5-class solution from the initial LCA, we conducted a 
MLCA to assess measurement invariance. Table 3 presents results of the consecutive nested 
models. When comparing these nested models, we found that sequentially adding direct 
effects of sex on classes and the interaction between sex and classes did not lead to a 
significant improvement of fit. Indeed the ∆L2 indicated a deterioration of fit. Hence, the 
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model comparison procedure indicated that the homogeneous model fit was better than that of 
all other models. Hence, sex did not cause measurement variance. From Table 3, we can thus 
conclude that patterns of aggression and psychological distress are not dependent on the sex 
of AAS users.  
Insert Table 3 about here 
We taxonomized the patterns of the five latent classes on four risk categories: low, 
mild, moderate, and high. Accordingly, class 1 (high aggression moderate distress users: 
HAMoD; 7.63%) was characterized by the highest levels of direct (i.e., physical and verbal 
aggression), indirect (i.e., anger and hostility), and moderate psychological distress. Class 2 
(moderate aggression distress users: MoAD; 18.64%) comprised moderate levels of direct and 
indirect aggression and psychological distress. Class 3 (moderate direct aggression-mild 
indirect aggression moderate distress users: ModA-MiiA MoD; 11.71%) were characterized 
by moderate levels of physical and verbal aggression, mild levels of anger and hostility, and 
moderate psychological distress. Class 4 (mild direct aggression-moderate indirect 
aggression-distress users: MidA-MoiAD; 11.62%) displayed mild levels of physical and 
verbal aggression, moderate levels of anger and hostility as well as psychological distress. 
Class 5 (low aggression mild distress users: LAMiD; 39.06%) were characterized by lowest 
levels of all the indicators of aggression and mild psychological distress. Figure 2 presents the 
patterns of aggression and psychological distress for the 5-class model.  
Insert Figure 2 about here 
In Table 4, we report the class proportions obtained from the selected model. It can be 
seen that there was an inverse proportional sex distribution of the subgroups. Specifically, the 
proportion of male AAS users in class 1 (HAMoD) was 91.67% while the proportion of 
female users was 08.33%. Also, class 2 (MoAD) consisted of 80.42% males and 19.58% 
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females. The third class (ModA-MiiA-MoD) included 32.46% of male AAS users and 
67.54% of female AAS users. Class 4 (MidA-MoiAD) consisted of 30.00% of male AAS 
users and 70.00% of female AAS users. Finally, the proportion of male users in the fifth class 
(LAMiD) was 10.51% and the proportion of female users was 89.49%. Table 4 indicates 
results from Wald test. From Table 4, sex was significantly related to class membership 
(Wald = 31.04, p < .001) with members of class 1 (HAMoD) more likely to be male (z = -
5.02, p < .001) whereas members of class 5 (LAMiD) were more likely to be female (z = 3.51, 
p < .001).  
Insert Table 4 about here 
DISCUSSION 
The present study examined discrete patterns of AAS male and female users based on 
measures of aggression and psychological distress using a multigroup latent class analysis. 
We also examined whether the identified patterns are applicable to both sexes. Five latent 
classes offered the best explanation for the patterns of physical aggression, verbal aggression, 
anger, hostility, and psychological distress: high aggression moderate distress (7.63%), low 
aggression mild distress (39.06%), moderate aggression distress (18.64%), moderate direct 
aggression-mild indirect aggression moderate distress (22.95%), and mild direct aggression-
moderate indirect aggression-distress (11.71%). Altogether, the proportional distribution of 
the identified subgroups indicates that while majority of AAS users are characterized by low 
to moderate aggression and psychological distress, about 8% display high aggression with 
mild psychological distress. Moreover, the proportional distribution denotes an idiosyncratic 
pattern of aggression and psychological distress in the current AAS-using sample, in line with 
previous indication from a study of APED users (Hildebrandt et al., 2014). The distribution is 
also in line with findings from previous studies in which AAS use had higher associations 
with increased hostility, irritability, and anger rather than direct aggression (Hildebrandt et al., 
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2014; Panagiotidis et al., 2017). The observed subgroups of AAS users with different profiles 
of aggression and psychological distress in the current study adds support to a previous 
systematic review suggesting that aggression and psychological distress are linked to AAS 
use but not in all subsets of AAS users (Trenton and Currier, 2005).  
Furthermore, results from the MLCA indicates that a homogenous model is most 
appropriate when determining male and female AAS users’ direct and indirect aggression and 
psychological distress profiles. Inferably, AAS users’ belongingness to specific subgroups is 
not sex-determined and the patterns of aggression and psychological distress identified in the 
present study is applicable to both males and females. Relatedly, the inverse proportional sex 
distribution of the subgroups, with the highly aggressive subgroup having significantly higher 
proportions of males whereas the low aggression subgroup comprise of significantly higher 
proportions of females, indicates that a higher proportion of males (compared to females) are 
at an elevated risk of aggression and psychological distress. This finding can also be 
explained by evidence of earlier AAS use initiation, more extensive use (e.g., higher weekly 
doses and higher number of AAS per cycle) as well as a higher prevalence of stacking, 
polypharmacy and pyramiding in males compared to females (Ip et al., 2010). Importantly, 
the present finding of an inverse proportional sex distribution of the subgroups is consistent 
with evidence from a recent meta-analysis of experimental studies showing that the 
association between endogenous testosterone levels as well as testosterone administration and 
aggression are stronger and significant in males but not females (Geniole et al., 2019).  
The current study’s findings can inform preventive as well as harm reduction and 
treatment interventions on AAS use, and aggression and psychological distress. Preventive 
interventions on AAS use incorporating education about the potential for aggressive behavior 
and psychological distress may be beneficial in reducing motivation and intention for AAS 
initiation (Bates et al., 2021; Petróczi et al., 2014; Sagoe et al., 2016). Similarly, it is 
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important that harm reduction and treatment interventions for AAS use is extended into the 
amelioration of aggression and psychological distress (Bates et al., 2019, 2021; Pope and 
Kanayama, 2021). In this regard, the homogenous gender model identified in this study 
underlines the indispensability of female AAS users in such policy making particularly in 
relation to the tendency for aggression and psychological distress. Furthermore, there is a 
need for more refined approaches to treatment and harm reduction in which the importance of 
AAS users’ different profiles of aggression and psychological distress are taken into 
consideration.  
The present findings should be interpreted in the context of limitations such as our 
reliance on self-reports which can be problematic for assessing substance use (Hickman et al., 
2002), and our inability to draw causal inferences due to the cross-sectional survey design. In 
the current study the average length of AAS use was 1.33 (SD = .56) years which equals to, at 
least, two cycles of AAS use (Hildebrandt et al., 2007). However, we do not know whether 
the participants were “on cycle” or “off cycle” when participating in the data collection. 
Moreover, the most popular AAS used by both sexes were oxandrolone/Anavar, testosterone, 
stanozolol/Winstrol, Dianabol/methandrostenolone, and Anadrol/oxymetholone in line with 
evidence from previous studies (Abrahin et al., 2017; Gruber and Pope, 2000). From these 
most frequently used types of AAS, only Anadrol (oxymetholone) is anecdotally associated 
with increased aggression in humans (Barker, 1987; Llewellyn, 2011). Hence, it is also 
plausible that factors such as particular AAS, AAS use method (e.g., ‘blast and cruise’, ‘blitz-
cycles’, ‘stacking’) and polypharmacy (Hildebrandt et al., 2007; Lundholm et al., 2015) as 
well as personality (Hauger et al., 2021), AAS dependence and cognition (Hauger et al., 
2019b), and premorbidity such as structural brain abnormalities (Bjørnebekk et al., 2017; 
Hauger et al., 2019a) account for the differences between the subgroups identified in the 
present study and further studies are encouraged to explore these.  
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Despite the abovementioned limitations, the current study has some notable strengths. 
First, to our knowledge, the current study represents a novel approach in examining discrete 
subgroups of aggression and psychological distress among male and female AAS users in 
particular. Another strength is our use of MLCA in the identification of subgroups and role of 
sex as this method is empirically superior to traditional categorization using cut-off points 
(Berzofsky et al., 2008). In addition, the preponderance of AAS research so far has been 
conducted largely on male samples in Western countries (Sagoe et al., 2014b; Sagoe and 
Pallesen, 2018). Further research using longitudinal designs may elucidate transitions between 
latent classes. An examination of the psychosocial correlates of AAS users’ belongingness to 
the subgroups identified in the present study may also be interesting. Finally, it could be of 
interest to replicate these subgroups and investigate the AAS types associated with members 
of each subgroup.  
CONCLUSION 
Using MLCA, we investigated the patterns of male and female AAS users’ aggression 
and psychological distress and whether the identified patterns can be applied to both sexes. 
We identified five discrete patterns of direct and indirect aggression and psychological 
distress with about 8% displaying the highest levels of aggression and mild psychological 
distress. Our findings also indicate that patterns of aggression and psychological distress are 
applicable to both male and female AAS users. Here, members of the high aggression and 
moderate psychological distress subgroup are more likely to be male whereas members of the 
low, mild, and/or moderate aggression and psychological distress subgroup are more likely to 
be female. Our study provides pioneering empirical evidence of the unique patterns of 
aggression and psychological distress among male and female AAS users. Our findings can 
be useful for preventive, harm reduction and treatment interventions on AAS use, and 




Abrahin, O., Félix Souza, N. S., de Sousa, E. C., Santos, A. M., & Bahrke, M. S. (2017). 
Anabolic–androgenic steroid use among Brazilian women: An exploratory 
investigation. Journal of Substance Use, 22, 246–252. doi: 
10.1016/j.drugpo.2020.102876 
Ali, S., & Garcia, J. M. (2014). Sarcopenia, cachexia and aging: diagnosis, mechanisms and 
therapeutic options-a mini-review. Gerontology, 60, 294–305. doi: 
10.1159/000356760 
Babor, T. F., & Caetano, R. (2006). Subtypes of substance dependence and abuse: 
implications for diagnostic classification and empirical research. Addiction, 101, 104–
110. doi: 10.1111/j.1360-0443.2006.01595.x 
Baggish, A. L., Weiner, R. B., Kanayama, G., Hudson, J. I., Lu, M. T., Hoffmann, U., & Pope 
Jr, H. G. (2017). Cardiovascular toxicity of illicit anabolic-androgenic steroid use. 
Circulation, 135, 1991–2002. doi: 10.1161/CIRCULATIONAHA.116.026945 
Bakk, Z., & Vermunt, J. K. (2016). Robustness of stepwise latent class modeling with 
continuous distal outcomes. Structural Equation Modeling, 23, 20–31. doi: 
10.1080/10705511.2014.955104 
Barker, S. (1987). Oxymethalone and aggression. British Journal of Psychiatry, 151, 564. doi: 
10.1192/S0007125000217698 
Bates, G., McVeigh, J., & Leavey, C. (2021). Looking beyond the provision of injecting 
equipment to people who use anabolic androgenic steroids: Harm reduction and 




Bates, G., Van Hout, M. C., Teck, J. T. W., & McVeigh, J. (2019). Treatments for people who 
use anabolic androgenic steroids: a scoping review. Harm Reduction Journal, 16, 1-
15. doi: 10.1186/s12954-019-0343-1 
Bensoussan, Y., & Anderson, J. (2019). Case report: The long‐term effects of anabolic 
steroids on the female voice over a 20‐year period. Clinical Case Reports, 7, 1067. 
doi: 10.1002/ccr3.2084 
Berzofsky, M., Biemer, P., & Kalsbeek, W. (2008). A brief history of classification error 
models. Section on Survey Research Methods-JSM, 3667–3673. 
Bjelland, I., Dahl, A. A., Haug, T. T., & Neckelmann, D. (2002). The validity of the Hospital 
Anxiety and Depression Scale: An updated literature review. Journal of 
Psychosomatic Research, 52, 69–77. doi: 10.1016/S0022-3999(01)00296-3 
Bjørnebekk, A., Walhovd, K. B., Jørstad, M. L., Due-Tønnessen, P., Hullstein, I. R., & Fjell, 
A. M. (2017). Structural brain imaging of long-term anabolic-androgenic steroid users 
and nonusing weightlifters. Biological Psychiatry, 82, 294–302. doi: 
10.1016/j.biopsych.2016.06.017 
Börjesson, A., Gårevik, N., Dahl, M. L., Rane, A., & Ekström, L. (2016). Recruitment to 
doping and help-seeking behavior of eight female AAS users. Substance Abuse 
Treatment, Prevention, and Policy, 11, 11. doi: 10.1186/s13011-016-0056-3 
Carré, J. M., Geniole, S. N., Ortiz, T. L., Bird, B. M., Videto, A., & Bonin, P. L. (2017). 
Exogenous testosterone rapidly increases aggressive behavior in dominant and 
impulsive men. Biological Psychiatry, 82, 249–256. doi: 
10.1016/j.biopsych.2016.06.009 
Chegeni, R., Sagoe, D., Mentzoni, R. A., & Pallesen, S. (2019). Aggression and anabolic–
androgenic steroid use intent in adolescents: A longitudinal study. Substance Use & 
Misuse, 54, 1509–1518. doi: 10.1080/10826084.2019.1589522 
18 
 
Cheung, A. S., & Grossmann, M. (2018). Physiological basis behind ergogenic effects of 
anabolic androgens. Molecular and Cellular Endocrinology, 464, 14–20. doi: 
10.1016/j.mce.2017.01.047 
Christiansen, A. V., Vinther, A. S., & Liokaftos, D. (2017). Outline of a typology of men’s 
use of anabolic androgenic steroids in fitness and strength training environments. 
Drugs: Education, Prevention & Policy, 24, 295–305. doi: 
10.1080/09687637.2016.1231173 
Christou, M. A., Christou, P. A., Markozannes, G., Tsatsoulis, A., Mastorakos, G., & Tigas, 
S. (2017). Effects of anabolic androgenic steroids on the reproductive system of 
athletes and recreational users: a systematic review and meta-analysis. Sports 
Medicine, 47, 1869–1883. doi: 10.1007/s40279-017-0709-z 
Clogg, C. C., & Goodman, L. A. (1985). Simultaneous latent structure analysis in several 
groups. Sociological Methodology, 15, 81–110. doi: 10.2307/270847  
Cohen, J., Collins, R., Darkes, J., & Gwartney, D. (2007). A league of their own: 
demographics, motivations and patterns of use of 1,955 male adult non-medical 
anabolic steroid users in the United States. Journal of the International Society of 
Sports Nutrition, 4, 1–14. doi: 10.1186/1550-2783-4-12 
Collins, L. M., & Lanza, S. T., (2010). Latent class and latent transition analysis: With 
applications in the social, behavioral, and health sciences (Vol. 718). New York: John 
Wiley & Sons.  
Cunningham, R. L., Lumia, A. R., & McGinnis, M. Y. (2013). Androgenic anabolic steroid 
exposure during adolescence: ramifications for brain development and behavior. 
Hormones and Behavior, 64, 350–356. doi: 10.1016/j.yhbeh.2012.12.009 
19 
 
Diamond, P. M., & Magaletta, P. R. (2006). The short-form Buss–Perry aggression 
questionnaire (BPAQ-SF). A validation study with federal offenders. Assessment, 13, 
227–240. doi: 10.1177%2F1073191106287666 
Evans-Polce, R., Lanza, S., & Maggs, J. (2016). Heterogeneity of alcohol, tobacco, and other 
substance use behaviors in US college students: A latent class analysis. Addictive 
Behaviors, 53, 80–85. doi: 10.1016/j.addbeh.2015.10.010 
Fayyazi Bordbar, M. R., Abdollahian, E., Samadi, R., & Dolatabadi, H. (2014). Frequency of 
use, awareness, and attitudes toward side effects of anabolic–androgenic steroids 
consumption among male medical students in Iran. Substance Use & Misuse, 49, 
1751–1758. doi: 10.3109/10826084.2014.880175 
Geniole, S. N., Bird, B. M., McVittie, J. S., Purcell, R. B., Archer, J., & Carré, J. M. (2019). 
Is testosterone linked to human aggression? A meta-analytic examination of the 
relationship between baseline, dynamic, and manipulated testosterone on human 
aggression. Hormones and Behavior, 104644. doi: 10.1016/j.yhbeh.2019.104644 
Goodman, L. A. (2007). On the assignment of individuals to latent classes. Sociological 
Methodology, 37, 1–22. doi: 10.1111%2Fj.1467-9531.2007.00184.x 
Grogan, S., Shepherd, S., Evans, R., Wright, S., & Hunter, G. (2006). Experiences of anabolic 
steroid use: in-depth interviews with men and women body builders. Journal of Health 
Psychology, 11, 845–856. doi: 10.1177%2F1359105306069080 
Gruber, A. J., & Pope Jr, H. G. (2000). Psychiatric and medical effects of anabolic-androgenic 
steroid use in women. Psychotherapy and Psychosomatics 69, 19–26. doi: 
10.1159/000012362 
Hagenaars, J. A. (1990). Categorical longitudinal data log-linear analysis of panel, trend and 
cohort data. Sage Publications Inc. 
20 
 
Hauger, L. E., Havnes, I. A., Jørstad, M. L., & Bjørnebekk, A. (2021). Anabolic androgenic 
steroids, antisocial personality traits, aggression and violence. Drug and Alcohol 
Dependence, 221, 108604. doi: 10.1016/j.drugalcdep.2021.108604 
Hauger, L. E., Sagoe, D., Vaskinn, A., Arnevik, E. A., Leknes, S., Jørstad, M. L., & 
Bjørnebekk, A. (2019b). Anabolic androgenic steroid dependence is associated with 
impaired emotion recognition. Psychopharmacology, 236, 2667–2676. doi: 
10.1007/s00213-019-05239-7 
Hauger, L. E., Westlye, L. T., Fjell, A. M., Walhovd, K. B., & Bjørnebekk, A. (2019a). 
Structural brain characteristics of anabolic androgenic steroid dependence in 
men. Addiction, 114, 1405–1415. doi: 10.1111/add.14629 
Havnes, I. A., Jørstad, M. L., Innerdal, I., & Bjørnebekk, A. (2020). Anabolic-androgenic 
steroid use among women–A qualitative study on experiences of masculinizing, 
gonadal and sexual effects. International Journal of Drug Policy, 102876. doi: 
10.1016/j.drugpo.2020.102876 
Havnes, I. A., Jørstad, M. L., & Wisløff, C. (2019). Anabolic-androgenic steroid users 
receiving health-related information; health problems, motivations to quit and 
treatment desires. Substance Abuse Treatment, Prevention, and Policy, 14, 20–31. doi: 
10.1186/s13011-019-0206-5 
Hickman, M., Taylor, C., Chatterjee, A., Degenhardt, L., Frischer, M., Hay, G., ... & 
McKetin, R. (2002). Estimating the prevalence of problematic drug use: a review of 
methods and their application. Bulletin on Narcotics, 54, 15–32. doi: 
10.1016/j.drugopo.2005.02.05 
Hildebrandt, T., Langenbucher, J. W., Carr, S. J., & Sanjuan, P. (2007). Modeling population 
heterogeneity in appearance-and performance-enhancing drug (APED) use: 
21 
 
Applications of mixture modeling in 400 regular APED users. Journal of Abnormal 
Psychology, 116, 717–733. doi: 10.1037/0021-843X.116.4.717 
Hildebrandt, T., Langenbucher, J. W., Flores, A., Harty, S., & Berlin, H. A. (2014). The 
influence of age of onset and acute anabolic steroid exposure on cognitive 
performance, impulsivity, and aggression in men. Psychology of Addictive Behaviors, 
28, 1096–1104. doi: 10.1037/a0036482 
Ip, E. J., Barnett, M. J., Tenerowicz, M. J., Kim, J. A., Wei, H., & Perry, P. J. (2010). Women 
and anabolic steroids: An analysis of a dozen users. Clinical Journal of Sport 
Medicine, 20, 475–481. doi: 10.1097/JSM.0b013e3181fb5370 
Jenssen, I. H., & Johannessen, K. B. (2015). Aggression and body image concerns among 
anabolic androgenic steroid users, contemplators, and controls in Norway. Body 
Image, 12, 6–13. doi: 10.1016/j.bodyim.2014.08.009 
Kankaraš, M., Moors, G., & Vermunt, J. K. (2010). Testing for measurement invariance with 
latent class analysis. In E. Davidov, P. Schmidt, & J. Billiet (Eds.), Cross-cultural 
analysis: Methods and applications (pp. 359–384). New York: Routledge 
Kaufman, M. J., Kanayama, G., Hudson, J. I., & Pope, H. G. (2019). Supraphysiologic-dose 
anabolic-androgenic steroid use: A risk factor for dementia?. Neuroscience & 
Biobehavioral Reviews, 100, 180–207. doi: 10.1016/j.neubiorev.2019.02.014 
Kicman, A. T. (2008). Pharmacology of anabolic steroids. British Journal of Pharmacology, 
154, 502–521. doi: 10.1038/bjp.2008.165 
Kjærgaard, M., Arfwedson Wang, C. E., Waterloo, K., & Jorde, R. (2014). A study of the 
psychometric properties of the Beck Depression Inventory-II, the Montgomery and 
Åsberg Depression Rating Scale, and the Hospital Anxiety and Depression Scale in a 




Krauss, M. J., Rajbhandari, B., Sowles, S. J., Spitznagel, E. L., & Cavazos-Rehg, P. (2017). A 
latent class analysis of poly-marijuana use among young adults. Addictive Behavior, 
75, 159–165. doi: 10.1016/j.addbeh.2017.07.021 
Lanza, S. T., & Rhoades, B. L. (2013). Latent class analysis: an alternative perspective on 
subgroup analysis in prevention and treatment. Prevention Science, 14, 157–168. doi: 
10.1007/s11121-011-0201-1 
Lazarsfeld, P. F. & Henry, N.W. (1968). Latent structure analysis. Boston, MA: Houghton 
Mifflin. 
Llewellyn, W. (2011). Anabolics. Molecular Nutrition LLC. 
Lundholm, L., Käll, K., Wallin, S., & Thiblin, I. (2010). Use of anabolic androgenic steroids 
in substance abusers arrested for crime. Drug and Alcohol Dependence, 111, 222–226. 
doi: 10.1016/j.drugalcdep.2010.04.020 
Lundholm, L., Frisell, T., Lichtenstein, P., & Langstrom, N. (2015). Anabolic androgenic 
steroids and violent offending: Confounding by polysubstance abuse among 10365 
general population men. Addiction, 110, 100–108. doi: 10.1111/add.12715 
Magidson, J., & Vermunt, J. K. (2002). Latent class modelling as a probabilistic extension of 
K-means clustering. Quirk’s Marketing Research Review, 3, 77–80. 
McCutcheon, A. L. (1987). Latent class analysis (No. 64). Sage. 
Montazeri, A., Vahdaninia, M., Ebrahimi, M., & Jarvandi, S. (2003). The Hospital Anxiety 
and Depression Scale (HADS): Translation and validation study of the Iranian version. 
Health and Quality of Life Outcome, 1, 14–18. doi: 10.1186/1477-7525-1-14 
Morean, M. E., Kong, G., Camenga, D. R., Cavallo, D. A., Simon, P., & Krishnan-Sarin, S. 
(2016). Latent class analysis of current e-cigarette and other substance use in high 




Nylund, K. L., Asparouhov, T., & Muthén, B. O. (2007). Deciding on the number of classes 
in latent class analysis and growth mixture modeling: A Monte Carlo simulation study. 
Structural Equation Modeling: A Multidisciplinary Journal, 14, 535–569. doi: 
10.1080/10705510701575396 
O'Connor, D. B., Archer, J., Hair, W. M., & Wu, F. C. (2002). Exogenous testosterone, 
aggression, and mood in eugonadal and hypogonadal men. Physiology & 
Behavior, 75, 557–566. doi: 10.1016/S0031-9384(02)00647-9 
Pagonis, P., Angelopoulos, N., Koukoulis, G. N., & Hadjichristodoulou, C. S. (2006). 
Psychiatric side effects induced by supraphysiological doses of combinations of 
anabolic steroids correlate to the severity of abuse. European Psychiatry, 21, 551–562. 
doi: 10.1016/j.eurpsy.2005.09.001 
Panagiotidis, D., Clemens, B., Habel, U., Schneider, F., Schneider, I., Wagels, L., & Votinov, 
M. (2017). Exogenous testosterone in a non-social provocation paradigm potentiates 
anger but not behavioral aggression. European Neuropsychopharmacology, 27, 1172–
1184. doi: 10.1016/j.euroneuro.2017.07.006 
Perry, P. J., Lund, B. C., Deninger, M. J., Kutscher, E. C., & Schneider, J. (2005). Anabolic 
steroid use in weightlifters and bodybuilders: An internet survey of drug utilization. 
Clinical Journal of Sport Medicine, 15, 326–330. doi: 
10.1097/01.jsm.0000180872.22426.bb 
Petróczi, A., Dodge, T., Backhouse, S. H., & Adesanwo, C. (2014). Review of the literature 
on negative health risks based interventions to guide anabolic steroid misuse 
prevention. Performance Enhancement & Health, 3, 31-44. doi: 
10.1016/j.peh.2014.08.001 




Pope Jr, H. G., & Kanayama, G. (2021). Neurobiology and treatment of anabolic-androgenic 
steroid-related disorders. In K.T. Brady, F. R. Levin, M. C. Galanter, & H. D. Kleber 
(eds.), The American Psychiatric Association publishing textbook of substance use 
disorder treatment (pp. 315-331). Washington, DC: American Psychiatric Association. 
Pope, H. G., Kouri, E. M., & Hudson, J. I. (2000). Effects of supraphysiologic doses of 
testosterone on mood and aggression in normal men: A randomized controlled 
trial. Archives of General Psychiatry, 57, 133–140. doi: 10.1001/archpsyc.57.2.133 
Team, R. (2015). RStudio: Integrated Development for R. RStudio. Inc., Boston, MA URL 
http://www.rstudio.com/. 
Sagoe, D. (2014). Nonmedical anabolic-androgenic steroid use: Prevalence, attitudes, and 
social perception (PhD thesis). Bergen: University of Bergen. 
Sagoe, D., Andreassen, C. S., & Pallesen, S. (2014b). The aetiology and trajectory of 
anabolic-androgenic steroid use initiation: A systematic review and synthesis of 
qualitative research. Substance Abuse Treatment, Prevention, and Policy, 9, 27–40. 
doi: 10.1186/1747-597X-9-27 
Sagoe, D., & Pallesen, S. (2018). Androgen abuse epidemiology. Current Opinion in 
Endocrinology & Diabetes and Obesity, 25, 185–194. doi: 
10.1097/MED.0000000000000403 
Sagoe, D., Holden, G., Rise, E. N. K., Torgersen, T., Paulsen, G., Krosshaug, T., Lauritzen, 
F., & Pallesen, S. (2016). Doping prevention through anti-doping education and 
practical strength training: The Hercules program. Performance Enhancement & 
Health, 5, 24–30. doi: 10.1016/j.peh.2016.01.001  
Sagoe, D., Mentzoni, R. A., Hanss, D., & Pallesen, S. (2016). Aggression is associated with 
increased anabolic-androgenic steroid use contemplation among adolescents. 
Substance Use & Misuse, 51, 1462–1469. doi: 10.1080/10826084.2016.1186696 
25 
 
Sagoe, D., Molde, H., Andreassen, C. S., Torsheim, T., & Pallesen, S. (2014a). The global 
epidemiology of anabolic-androgenic steroid use: A meta-analysis and meta-
regression analysis. Annals of Epidemiology, 24, 383–398. doi: 
10.1016/j.annepidem.2014.01.009 
Samani, S. (2008). Study of reliability and validity of the Buss and Perry's aggression 
questionnaire. Iranian Journal of Psychiatry and Clinical Psychology, 13, 359–365. 
Santos, A. M. (2014). Body Image and Bodybuilding Culture in Three Brazilian Gyms: A 
Qualitative Analysis. Brazil: Federal University of Bahia. 
Schwarz, G. (1978). Estimating the dimension of a model. The Annals of Statistics, 6, 461–
464. 
Shin, S. H., Hong, H. G., & Hazen, A. L. (2010). Childhood sexual abuse and adolescent 
substance use: A latent class analysis. Drug and Alcohol Dependence, 109, 226–235. 
doi: 10.1016/j.drugalcdep.2010.01.013 
Syvertsen, J., Pollini, R. A., Lozada, R., Vera, A., Rangel, G., & Strathdee, S. A. (2010). 
Managing la malilla: Exploring drug treatment experiences among injection drug users 
in Tijuana, Mexico, and their implications for drug law reform. International Journal 
of Drug Policy, 21, 459–465. doi: 10.1016/j.drugpo.2010.06.006 
Tragger, J. (1988). Beware "roid rage" in athletes. Medical Tribune, 29, 1–13. 
Trenton, A. J., & Currier, G. W. (2005). Behavioural manifestations of anabolic steroid 
use. CNS Drugs, 19, 571-595. doi: 10.2165/00023210-200519070-00002 
Vermunt, J. K., & Magidson, J. (2016). Technical Guide for Latent GOLD 5.1: Basic, 
Advanced, and Syntax. Belmont, MA: Statistical Innovations Inc. 
Værøy, H. (2013). Aggression questionnaire scores in extremely violent male prisoners, male 




Wagels, L., Votinov, M., Kellermann, T., Eisert, A., Beyer, C., & Habel, U. (2018). 
Exogenous testosterone enhances the reactivity to social provocation in 
males. Frontiers in Behavioral Neuroscience, 12, 37. doi: 10.3389/fnbeh.2018.00037 
Zahnow, R., McVeigh, J., Bates, G., Hope, V., Kean, J., Campbell, J., & Smith, J. (2018). 
Identifying a typology of men who use anabolic androgenic steroids (AAS). 
International Journal of Drug Policy, 55, 105–112. doi: 10.1016/j.drugpo.2018.02.022 
Zhang, H., Qu, W., Ge, Y., Sun, X., & Zhang, K. (2017). Effect of personality traits, age and 
sex on aggressive driving: Psychometric adaptation of the Driver Aggression 
Indicators Scale in China. Accident Analysis & Prevention, 103, 29–36. doi: 
10.1016/j.aap.2017.03.016 
Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta 








 Overall  
(N = 206) 
   Male  
(n = 86) 
 Female  
(n = 120) 
Variable Range Mean (SD)   Mean (SD)  Mean (SD) 
Age (years) 14–56 26.89 (7.12)   26.69 (6.72)  27.04 (7.44) 
Height (cm) 154–192 171. 54 (9.66)   180.46 (6.09)  165.11 (5.91) 
Weight (kg) 45–170 71.53 (17.23)   84.64 (16.23)  62.06 (10.41) 
Weight training        
       Total years  1–36 3.28 (4.02)   3.52 (4.96)  3.08 (3.04) 
       Days per week 1–7 3.40 (1.49)   3.97 (1.62)  2.97 (1.23) 
       Hours per week 1–20 5.12 (4.66)   6.19 (5.85)  4.37 (3.38) 
AAS use duration (years) 1–3 1.33 (.56)   1.51 (.66)  1.19 (.43) 
  N (%)   n (%)  n (%) 
Highest education        
       High School  12 (5.80)   5 (5.80)  7 (5.80) 
       Diploma  35 (17.00)   16 (18.60)  19 (15.80) 
       Technician  20 (9.7)   8 (9.30)  12 (10.00) 
       Bachelor  92 (44.70)   39 (45.30)  53 (44.20) 
       Master  34 (16.5)   14 (16.30)  20 (16.70) 
       PhD   10 (4.9)   1 (1.2)  9 (7.50) 
Marriage status        
       Single  153 (74.30)   67 (77.90)  86 (71.70) 
       Married  52 (25.20)   18 (20.90)  34 (28.30) 
Work status        
       Full time  58 (28.20)   30 (34.90)  28 (23.30) 
       Part time  28 (13.60)   7 (8.10)  21 (17.50) 
       Self-employed  38 (18.40)   24 (27.90)  14 (11.70) 
       Unemployed  34 (16.50)   8 (9.3)  26 (21.70) 
       Student  40 (19.40)   14 (16.30)  26 (21.70) 
Sports involvement        
       Competitive sport  6 (2.90)   4 (4.70)  2 (1.70) 
       Recreational sport  34 (16.50)   17 (19.80)  17 (14.20) 
       Competitive bodybuilding  30 (14.60)   10 (11.60)  20 (16.70) 
       Recreational bodybuilding  105 (51.00)   52 (60.50)  53 (44.20) 
  N   n  n 
AAS type useda        
      Anadrol (Oxymetholone) 62   39  23 
      Anavar (Oxandrolone) 112   57  55 
      Deca-Durabolin (Nanrolone decanoate) 47   30  17 
      Depo-Testosterone  7   6  1 
      Dianabol (Methandrostenolone) 71   38  33 
      Durabolin   7   2  5 
      Equipoise (Boldenone) 12   8  4 
      Finajet (Trenbolone)  12   9  3 
      Maxibolim (Ethylestrenol) 2   2  0 
      Methyltestosterone  4   4  0 
      Primobolan  9   4  5 
      Stanozolol (Winstrol)  136   96  40 
      Steroid cocktail  3   1  2 
      Sustanon  44   21  23 
      Testosterone  114   66  48 








Fit statistics for the latent class analysis. 
Model  BIC (LL) N par L2 ACE (%) 
1-class 4857.99 75 2878.33 0.00 
2-class 4438.13 81 2426.71 0.01 
3-class 4349.63 87 2306.45 0.02 
4-class 4338.65 93 2263.71 0.03 
5-class 4326.81 99 2220.11 0.02 
6-class 4330.37 105 2191.91 0.03 
BIC: Bayesian Information Criteria. N par: Number of parameters in the model. L2: Squared log-






























Fit statistics of the estimated five-class multigroup latent class models 
Model BIC 
(LL) 
L2 df Comparison ΔL2 Sig. result  
Homogeneous model (HM) 4326.81 2220.11 100 — — — 
Adding direct effect of sex on one indicator at a time 
     Physical aggression (PA) 4408.85 2500.22 88 HM vs. PA -148.40 Deterioration 
     Verbal aggression (VA) 4417.60 2445.45 76 HM vs. VA -145.99 Deterioration 
     Anger (A) 4412.08 2397.58 68 HM vs. A -144.70 Deterioration 
     Hostility (H) 4369.70 2291.68 56 HM vs. H -127.40 Deterioration 
Partially homogeneous model (PHM) 
with all direct effects included 
4411.33 2190.40 30 HM vs. 
PHM 
29.71 Deterioration 
Heterogeneous model (HeM) 2008.66 2315.42 75 HM vs. HeM -90.65 Deterioration 
BIC: Bayesian Information Criteria. N par: Number of parameters in the model. L2: Squared log-




TABLE 4.  
Proportions of male and female AAS users in latent classes of aggression and psychological 
distress   






Male 91.67 80.42 32.46 30.00 10.51 
Female 8.33 19.58 67.54 70.00 89.49 
Total 07.36 18.64 22.95 11.71 39.06 
Wald test§ -5.02* -0.52 1.19 1.76 3.51* 
HAMoD: high aggression moderate distress users (07.63%). MoAD: moderate aggression 
distress users (18.64%). ModA-MiiA MoD: moderate direct aggression-mild indirect 
aggression moderate distress users (22.95%). MidA-MioAD: mild direct aggression-
moderate indirect aggression-distress users (11.71%). LAMiD: low aggression mild distress 
users (39.06%). 
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